Im Shop erwerben
, um zu prüfen, ob Sie einen Vollzugriff auf diese Publikation haben.
Monographie Kein Zugriff

Aufholende Entwicklung in der globalen Ökonomie

Pharmazeutische Innovationssysteme in Indien und Brasilien
Autor:innen:
Verlag:
 2015

Zusammenfassung

Der Zugang zu technologischem Wissen ist ein Schlüsselfaktor für die ökonomische und soziale Entwicklung aufholender Länder. Gleichzeitig wird dieser durch das im TRIPs-Abkommen verankerte Patentschutzgebot seit Mitte der 1990er Jahre erheblich beschränkt. Am folgenreichsten ist hiervon der pharmazeutische Sektor betroffen, der wegen seiner hohen Technologieintensität und sozialpolitischen Relevanz in aufholenden Ländern seit jeher vom Patentschutz ausgenommen war.

Die Arbeit untersucht die pharmazeutische Technologiegewinnung Indiens und Brasiliens. Es wird gezeigt, dass die beiden Staaten infolge des TRIPs-Abkommens zwei grundlegend verschiedene catching up-Pfade eingeschlagen haben, die auf unterschiedliche Governance-Konfigurationen in den Innovationssystemen beider Länder zurückgeführt werden können.

Publikation durchsuchen

Bibliographische Angaben

Auflage
1/2015
Copyrightjahr
2015
ISBN-Print
978-3-8487-2132-0
ISBN-Online
978-3-8452-6232-1
Verlag
Nomos, Baden-Baden
Reihe
Vergleichende Analyse politischer Systeme
Band
6
Sprache
Deutsch
Seiten
394
Produkttyp
Monographie

Inhaltsverzeichnis

KapitelSeiten
  1. Titelei/Inhaltsverzeichnis Kein Zugriff 1 - 18
  2. Verzeichnis der Fallbeispiele Kein Zugriff 19 - 20
  3. Einleitung Kein Zugriff 21 - 31
  4. Die Globalisierung pharmazeutisch-technologischer Wissensgewinnung Kein Zugriff 32 - 65
  5. Theoretische Grundlagen: Governance von technologischer Wissensgewinnung Kein Zugriff 66 - 101
  6. Konzept und Methode Kein Zugriff 102 - 127
  7. Indien: Exportorientierte Innovationsförderung durch Markt-Governance Kein Zugriff 128 - 213
  8. Brasilien: Binnenorientierte Versorgungssicherheit durch Hierarchie Kein Zugriff 214 - 303
  9. Vergleich: Pharmazeutische Innovationssysteme in Indien und Brasilien Kein Zugriff 304 - 330
  10. Schlussbetrachtung Kein Zugriff 331 - 353
  11. Quellen- und Literaturverzeichnis Kein Zugriff 354 - 394

Literaturverzeichnis (647)

  1. Rau, B. S. & P. V. Appaji (2012), Dynamics of Drug Master Filings at United States Food and Drug Administration, The Pharma Review,(May-June), 65-71. Google Scholar öffnen DOI: 10.5771/9783845262321
  2. Ravenhill, John (2014), Global value chains and development, Review of International Political Economy, 21(1), 264-274. Google Scholar öffnen DOI: 10.5771/9783845262321
  3. Reddy, Madhuri et al. (2007), Oral Drug Therapy for Multiple Neglected Tropical Diseases: A Systematic Review, JAMA - The Journal of the American Medical Association, 298(16), 1911-1924. Google Scholar öffnen DOI: 10.5771/9783845262321
  4. Reh, Werner (1995), Quellen- und Dokumentenanalyse in der Politikfeldforschung: Wer steuert die Verkehrspolitik?, in: Ulrich von Alemann et al. (Hrsg.), Politikwissenschaftliche Methoden: Grundriß für Studium und Forschung, Opladen: Westdeutscher Verlag, 201-260. Google Scholar öffnen DOI: 10.5771/9783845262321
  5. Reichman, Jerome H. (2002), From Free Riders to Fair Followers: Global Competition under the TRIPS Agreement, in: Ruth Towse & Rudi Holzhauer (Hrsg.), The Economics of Intellectual Property. Competition and International Trade, IV, Cheltenham: Edward Elgar, 446-527. Google Scholar öffnen DOI: 10.5771/9783845262321
  6. Reis, Carla, João Pieroni Pieroni & José Oswaldo Barros de Souza (2010), Biotecnologia para saúde no Brasil, BNDES Setorial, 32, 193-230. Google Scholar öffnen DOI: 10.5771/9783845262321
  7. Reis, Renata, Marcela Foçaça Vieira & Gabriela Costa Chaves (2009), Access to medicines and intellectual property in Brazil: A civil society perspective, in: Renata Reis et al. (Hrsg.), Intellectual Property Right and Access to ARV Medicines - Civil Society Resistance in the Global South, Rio de Janeiro: ABIA, 12-54. Google Scholar öffnen DOI: 10.5771/9783845262321
  8. Reuters (2012), Novartis argues for Glivec patent at India's top court, 11.09.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  9. Rezaie, Rahim (2011), Health Technology Innovation by Indigenous Enterprises in China, India and Brazil, A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy, Toronto: University of Toronto, Institute of Medial Science. Google Scholar öffnen DOI: 10.5771/9783845262321
  10. Rezaie, Rahim et al. (2008), Brazilian health biotech - fostering crosstalk between public and private sectors, Nature Biotechnology, 26(6), 627 - 644. Google Scholar öffnen DOI: 10.5771/9783845262321
  11. Richards, Caroline (2011), BRIC: Pricing, Reimbursement, and Regulatory Update, London: Datamonitor. Google Scholar öffnen DOI: 10.5771/9783845262321
  12. Risse, Thomas & Ursula Lehmkuhl (2007), Regieren ohne Staat? Governance in Räumen begrenzter Staatlichkeit, Baden-Baden: Nomos. Google Scholar öffnen DOI: 10.5771/9783845262321
  13. Rodrik, Dani (1997), Has Globalization Gone Too Far?, Washington, D.C.: Institute for International Economics. Google Scholar öffnen DOI: 10.5771/9783845262321
  14. Roemer-Mahler, Anne (2013), Business conflict and global politics: The pharmaceutical industry and the global protection of intellectual property rights, Review of International Political Economy, 20(1), 121-152. Google Scholar öffnen DOI: 10.5771/9783845262321
  15. Rogers, Everett M. (2003), Diffusion of Innovations, New York: Free Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  16. Romer, Paul Michael (1994), The Origins of Endogenous Growth, Journal of Economic Perspectives, 8(1), 3-22. Google Scholar öffnen DOI: 10.5771/9783845262321
  17. Rostow, Walt Whitman (1960), The Stages of Economic Growth: A Non-Communist Manifesto, Cambridge: Cambridge University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  18. Ryan, Michael P. (2010), Patent Incentives, Technology Markets, and Public–Private Bio-Medical Innovation Networks in Brazil, World Development, 38(8), 1082-1093. Google Scholar öffnen DOI: 10.5771/9783845262321
  19. Saha, Raghav (2012), National Study on Intellectual Property and Small and Medium Sized Enterprises: India, Geneva: World Intellectual Property Organization, September. Google Scholar öffnen DOI: 10.5771/9783845262321
  20. Salama, Bruno & Daniel Benoliel (2010), Pharmaceutical Patent Bargains: The Brazilian Experience, Cardozo Journal of International and Comparative Law 18, 633-682. Google Scholar öffnen DOI: 10.5771/9783845262321
  21. Sampath, Padmashree Gehl (2010), Economic Aspects of Access to Medicines after 2005: Product Patent Protection and Emerging Firm Strategies in the Indian Pharmaceutical Industry, Maastricht: United Nations University, Institute for New Technologies. Google Scholar öffnen DOI: 10.5771/9783845262321
  22. San Francisco Bay Guardian (2005), Balm of Gilead: Local activists back Brazil's demand that US companies allow the creation of cheap, generic AIDS drugs, 05.07.05. Google Scholar öffnen DOI: 10.5771/9783845262321
  23. Saraswathy, Beena (2006), Mergers and Acquisitions in the Indian Pharmaceutical Industry: Nature, Structure and Performance, MPRA Papers, No. 8144, Munich: University Library of Munich. Google Scholar öffnen DOI: 10.5771/9783845262321
  24. Sartori, Giovanni (1991), Comparing and Miscomparing, Journal of Theoretical Politics, 3(3), 243-257. Google Scholar öffnen DOI: 10.5771/9783845262321
  25. Sartori, Laura (2009), Consumption in Developing Nations, in: Salustiano del Campo (Hrsg.), Encyclopedia of Life Support Systems, VII, Oxford: EOLSS. Google Scholar öffnen DOI: 10.5771/9783845262321
  26. Saúde Web (2012), Padilha assina 20 parcerias para produção de medicamentos e vacinas, <http://saudeweb.com.br/33473/padilha-assina-20-parcerias-para- Google Scholar öffnen DOI: 10.5771/9783845262321
  27. producao-de-medicamentos-e-vacinas/>. Google Scholar öffnen DOI: 10.5771/9783845262321
  28. Scerri, Mario & Helena Lastres (2010), Comparative Report on the State and the National System of Innovation in BRICS, BRICS Project, Rio de Janeiro. Google Scholar öffnen DOI: 10.5771/9783845262321
  29. Scerri, Mario & Helena M. M. Lastres (Hrsg.) (2013a), The Role of the State, New Delhi: Routledge. Google Scholar öffnen DOI: 10.5771/9783845262321
  30. Scerri, Mario & Helena M. M. Lastres (2013b), The State and the Architecture of National Systems of Innovation, in: Mario Scerri & Helena M. M. Lastres (Hrsg.), The Role of the State, New Delhi: Routledge, 1-22. Google Scholar öffnen DOI: 10.5771/9783845262321
  31. Scharpf, Fritz W. (1997), Games Real Actors Play: Actor-Centered Institutionalism in Policy Research, Boulder: Westview Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  32. Scharpf, Fritz W. (2000), Interaktionsformen: Akteurzentrierter Institutionalismus in der Politikforschung, Wiesbaden: VS Verlag für Sozialwissenschaften. Google Scholar öffnen DOI: 10.5771/9783845262321
  33. Schneider, Volker & Frank Janning (2006), Politikfeldanalyse: Akteure, Diskurse und Netzwerke in der öffentlichen Politik, Wiesbaden: VS Verlag für Sozialwissenschaften. Google Scholar öffnen DOI: 10.5771/9783845262321
  34. Schöne, Helmar (2005), Die teilnehmende Beobachtung als Datenerhebungsmethode in der Politikwissenschaft: Methodologische Reflexion und Werkstattbericht, Historical Social Research, 30(1), 168-199. Google Scholar öffnen DOI: 10.5771/9783845262321
  35. Schumacher, Christian (2012), CRAMS outsourcing in pharmaceutical and chemical research and manufacturing, part III, Science and Technology Blog, 03.09.12, <http://blog.stepchange-innovations.com/2012/09/crams-outsourc Google Scholar öffnen DOI: 10.5771/9783845262321
  36. ing-in-pharmaceutical-and-chemical-research-and-manufactu Google Scholar öffnen DOI: 10.5771/9783845262321
  37. ring-part-iii/#.UhONQ23TLW5>. Google Scholar öffnen DOI: 10.5771/9783845262321
  38. Schumpeter, Joseph (1934), The Theory of Economic Development: An Inquiry Into Profits, Capital, Credit, Interest, and the Business Cycle, Port Washington: Kennikat. Google Scholar öffnen DOI: 10.5771/9783845262321
  39. Seitz, Konrad (2000), Die neue Welt der Geo-Ökonomie: Das globale Ringen um die technologische Vorherrschaft, in: Karl Kaiser & Hans-Peter Schwarz (Hrsg.), Weltpolitik im neuen Jahrhundert, Baden-Baden: Nomos, 307-326. Google Scholar öffnen DOI: 10.5771/9783845262321
  40. Sell, Susan (1995), Intellectual Property Protection and Antitrust in the Developing World, International Organization, 49(2), 315-349. Google Scholar öffnen DOI: 10.5771/9783845262321
  41. Sell, Susan (2006), Intellectual Property and the Doha Development Agenda, Global Social Policy, 6(2), 147-150. Google Scholar öffnen DOI: 10.5771/9783845262321
  42. Sennes, Ricardo Ubiraci, Gabriel Kohlmann & Anselmo Takaki (2011), Os movimentos das multinacionais e a internacionalização da pesquisa, desenvolvimento e inovação, in: Ricardo Ubiraci Sennes & Antonio Britto Filho (Hrsg.), Inovações tecnológicas no Brasil, São Paulo: Cultura Acadêmica, 127-146. Google Scholar öffnen DOI: 10.5771/9783845262321
  43. Serra, Narcis & Joseph E. Stiglitz (Hrsg.) (2008), The Washington Consensus Reconsidered: Towards a New Global Governance, Oxford: Oxford University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  44. Shadlen, Kenneth C. (2007), The Political Economy of AIDS Treatment: Intellectual Property and the Transformation of Generic Supply, International Studies Quarterly, 51(3), 559-581. Google Scholar öffnen DOI: 10.5771/9783845262321
  45. Shadlen, Kenneth C. (2008), Revolution, Reform, and Reinforcement: Latin American Responses to the Globalization of Intellectual Property, ECPR Joint Sessions Workshop No. 14: "The Politics of Intellectual Property", Rennes, 11.-16. April. Google Scholar öffnen DOI: 10.5771/9783845262321
  46. Shadlen, Kenneth C. (2009a), The Political Contradictions of Incremental Innovation in Late Development: Lessons from Pharmaceutical Patent Examination in Brazil, American Political Science Association, 2009 Annual Meeting and Exhibition, Toronto, 03.-06. September. Google Scholar öffnen DOI: 10.5771/9783845262321
  47. Shadlen, Kenneth C. (2009b), Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies, Comparative Politics, 42(1), 41-58. Google Scholar öffnen DOI: 10.5771/9783845262321
  48. Shadlen, Kenneth C. (2013), The Patent Policy Trilemma, Journal für Entwicklungspolitik, 29(2), 87-104. Google Scholar öffnen DOI: 10.5771/9783845262321
  49. Shadlen, Kenneth C. (2011), The Political Contradictions of Incremental Innovation: Lessons from Pharmaceutical Patent Examination in Brazil, Politics & Society 39(2), 143-174. Google Scholar öffnen DOI: 10.5771/9783845262321
  50. Shankland, Ben (2008), Novartis Seeks to Form Partnerships with Health Providers in Brazil, Global Insight, 04.04.08. Google Scholar öffnen DOI: 10.5771/9783845262321
  51. Sharif, Naubahar (2006), Emergence and development of the National Innovation Systems concept, Research Policy, 35(5), 745-766. Google Scholar öffnen DOI: 10.5771/9783845262321
  52. Shaver, Lea (2010), Access to Knowledge in Brazil: New Research on Intellectual Property, Innovation and Development, Hofstra University School of Law Legal Studies Research Paper Series Research Paper 10-49 Google Scholar öffnen DOI: 10.5771/9783845262321
  53. Shiva, Vandana (2001), Protect or Plunder? Understanding Intellectual Property Rights, London: Zed Books. Google Scholar öffnen DOI: 10.5771/9783845262321
  54. Singh, Malvinder Mohan (2006), Will India Become the Global Centre for Pharmaceutical Research & Development?, Journal of Generic Medicines, 3(3), 194-200. Google Scholar öffnen DOI: 10.5771/9783845262321
  55. Sivaraman, R. (2012), Bayer plea against Natco on cancer drug dismissed, The Hindu, 16.09.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  56. Skocpol, Theda & Margaret Somers (1980), The Uses of Comparative History in Macrosocial Inquiry, Comparative Studies in Society and History, 22(2), 174-197. Google Scholar öffnen DOI: 10.5771/9783845262321
  57. Sleeboom, Margaret (2003), Monitored Freedom: Party and Research Reforms at CASS, China Report, 39(2), 213-227. Google Scholar öffnen DOI: 10.5771/9783845262321
  58. Solingen, Etel (1996), Industrial policy, technology, and international bargaining: design-ing nuclear industries in Argentina and Brazil, Stanford: Stanford University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  59. Spicy IP (2008), Roche vs NATCO: India's First "Doha Style" Compulsory License?, 16.01.08. Google Scholar öffnen DOI: 10.5771/9783845262321
  60. Spicy IP (2010a), Breaking News: Matrix Restrained from Infringing Roche’s Cancer Patent, 19.09.10. Google Scholar öffnen DOI: 10.5771/9783845262321
  61. Spicy IP (2010b), DIPP Discussion Paper on Compulsory Licensing in the Indian Pharmaceutical Sector: An 'Acquired' Afterthought?, 25.08.10. Google Scholar öffnen DOI: 10.5771/9783845262321
  62. Spicy IP (2010c), DIPP receives diverse replies to its CL discussion paper, 08.10.10. Google Scholar öffnen DOI: 10.5771/9783845262321
  63. Spicy IP (2010d), Guest Post: Requiem for a Dream?, 30.08.10. Google Scholar öffnen DOI: 10.5771/9783845262321
  64. Spicy IP (2010e), Indian "Bayh Dole" and a Painful End to the Pursuit of Pleasure, 10.08.10. Google Scholar öffnen DOI: 10.5771/9783845262321
  65. Spicy IP (2010f), Indian IP Policy Formulation: From Confusion to Coherence, 22.03.10. Google Scholar öffnen DOI: 10.5771/9783845262321
  66. Spicy IP (2010g), An overview of the 'Health Impact Fund' model for accessible medicines, 06.07.10. Google Scholar öffnen DOI: 10.5771/9783845262321
  67. Spicy IP (2010h), Roche-Natco update: "Public interest" again?, 17.05.10. Google Scholar öffnen DOI: 10.5771/9783845262321
  68. Spicy IP (2010i), Roche-Natco update: Natco commences arguments, 28.06.10. Google Scholar öffnen DOI: 10.5771/9783845262321
  69. Spicy IP (2010j), Roche-Natco update: Roche concludes arguments, 30.05.10. Google Scholar öffnen DOI: 10.5771/9783845262321
  70. Spicy IP (2011a), CIPLA files for a compulsory license against Merck's Isentress, 06.04.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  71. Spicy IP (2011b), Debating the legality and the efficacy of the CSIR-Patent Office agreement to out-source prior art searches, 18.12.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  72. Spicy IP (2011c), Natco seeks license from Pfizer to manufacture a low-cost version of HIV drug, 06.01.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  73. Spicy IP (2011d), A Small Step for Natco, a Giant Leap for Generic Drugs: India’s first Compulsory Licensing Application Filed, 05.08.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  74. Spicy IP (2012a), Breaking news: Cipla succeeds in revoking Pfizer / Sugen's patent on Sunitinib, 03.10.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  75. Spicy IP (2012b), Breaking News: India's First Compulsory License Granted!, 12.03.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  76. Spicy IP (2012c), CSIR provides misleading information; aims to hide revenues from patent licensin, 22.09.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  77. Spicy IP (2012d), CSIR pulls a fast one – does a U-Turn on disclosure of royalties earned through patent licensing, 13.09.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  78. Spicy IP (2012e), Guest Post: Pharma patent developments in 2012 - A review, 31.12.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  79. Spicy IP (2012f), National Science Day – The good and bad of Indian policy initiatives for scientific research and innovation, 27.02.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  80. Spicy IP (2012g), Part I: IPCheckups & Intellectual Ventures: What are they about?, 12.11.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  81. Spicy IP (2012h), Royalty Payment by Subsidiaries: Bane of Minority Investors?, 23.12.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  82. Spicy IP (2012i), Why is it so difficult for CSIR to be ‘transparent’?, 07.04.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  83. Spicy IP (2013a), The BDR compulsory licensing application and the BMS ‘Statements of Working’, 22.08.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  84. Spicy IP (2013b), Breaking News: Second Compulsory Licensing Application Filed, 17.03.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  85. Spicy IP (2013c), The Dasatinib compulsory license conundrum, 16.09.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  86. Spicy IP (2013d), DIPP to issue CLs for Herceptin, Dastinib & Ixabepilone – End of the line for Big Pharma’s patents in the Indian market?, 12.01.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  87. Spicy IP (2013e), The ‘Emcure model’ of Foreign Investment and Joint-Ventures, 31.01.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  88. Spicy IP (2013f), Negotiating licenses between patent holders and generic producers: the Medicines Patent Pool, 28.06.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  89. Spicy IP (2013g), Patent Ambush: Big Pharma vs Generics, 25.01.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  90. Spicy IP (2013h), Patent war intensifies: Glenmark launches generic version of Merck’s Januvia, 02.04.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  91. Spicy IP (2013i), The Royalty Payment Siphon by MNCs - Independent Director and Minority Voting as Possible Solutions?, 09.01.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  92. Spicy IP (2013j), SpicyIP Events: FMC-DSIR-APTDC Workshop for Identifying the Technologies for Acquisition, 13.06.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  93. Spicy IP (2013k), Why aren’t there any takers for compulsory licenses?, 12.02.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  94. Srholec, Martin (2011), A multilevel analysis of innovation in developing countries, Industrial and Corporate Change, 20(6), 1539-1569. Google Scholar öffnen DOI: 10.5771/9783845262321
  95. Srinivasan, Sandhya (2009), The Clinical Trials Scenario in India, Economic & Political Weekly, 44(35). Google Scholar öffnen DOI: 10.5771/9783845262321
  96. Steffen Guise, Mônica & Adelina de Oliveira Novaes (2011), Balancing Health and Wealth: The Case of Patents and Access to Medicines in Brazil. Google Scholar öffnen DOI: 10.5771/9783845262321
  97. Stewart, Frances (1977), Technology and Underdevelopment, London: Macmillan. Google Scholar öffnen DOI: 10.5771/9783845262321
  98. Stewart, Frances (1984), Facilitating Indigenous Technical Change in Third World Countries, in: Martin Fransman & Kenneth King (Hrsg.), Technological Capability in the Third World, London: Macmillan, 81-94. Google Scholar öffnen DOI: 10.5771/9783845262321
  99. Sundar, Mahesh (2013), Glenmark's Unique Indian Approach to successful NCE Research, <http://www.maheshsundar.com/Home/recent-developments-views-opin Google Scholar öffnen DOI: 10.5771/9783845262321
  100. ions-in-pharma-archives/glenmark-s-unique-indian-approach-to-success Google Scholar öffnen DOI: 10.5771/9783845262321
  101. ful-nce-research>. Google Scholar öffnen DOI: 10.5771/9783845262321
  102. Sweet, Cassandra M. (2007), Regulating the Tigers: The Institutional Dynamics of Indo-Brazilian Trade Reflections from the Pharmaceutical Sector, ELSNIT Conference, Institutional Dimensions of Integration and Trade, Barcelona, 01. Oktober. Google Scholar öffnen DOI: 10.5771/9783845262321
  103. Tachinardi, Maria Helena (1993), A Guerra Das Patentes: O conflito Brasil x EUA sobre propriedade intelectual, Sao Paulo: Paz e Terra. Google Scholar öffnen DOI: 10.5771/9783845262321
  104. TB Alliance (2013), TB Alliance Licenses Late-stage TB Program to CSIR-OSDD, 20.03.13, <http://www.tballiance.org/newscenter/view-brief.php?id=1076>. Google Scholar öffnen DOI: 10.5771/9783845262321
  105. Thach, Sharon & Susan J. Marsnik (2009), Patent Standards under TRIPS and the Pharmaceutical Industries in Brazil and India, Latin American Business Review, 10(4), 237-261. Google Scholar öffnen DOI: 10.5771/9783845262321
  106. The Indian Express (2011), Lupin inks pact with Brazil for TB drug supply, 05.01.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  107. The Indian Express (2013a), CCI rules out case against US-based pharmaceutical, Gilead Sciences, 12.03.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  108. The Indian Express (2013b), Govt moves to make three key cancer drugs cheaper, 12.01.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  109. The Observatory (2010), The Observatory of Economic Complexity, Massachusetts Institute of Technology, <http://atlas.media.mit.edu/>. Google Scholar öffnen DOI: 10.5771/9783845262321
  110. ThePharmaLetter (2001), Wockhardt acquires all Rhein Biotech JV, 11.09.01. Google Scholar öffnen DOI: 10.5771/9783845262321
  111. ThePharmaLetter (2005), Wockhardt sets up JVs in Latin America and South Africa, 21.02.05. Google Scholar öffnen DOI: 10.5771/9783845262321
  112. Thorelli, Hans B. (1986), Networks: Between Markets and Hierarchies, Strategic Management Journal, 7(1), 37-51. Google Scholar öffnen DOI: 10.5771/9783845262321
  113. Thorsteinsdóttir, Halla et al. (2004a), Conclusions: Promoting Biotechnology Innovation in Developing Countries, Nature Biotechnology, 22 (12s), DC48-DC52. Google Scholar öffnen DOI: 10.5771/9783845262321
  114. Thorsteinsdóttir, Halla et al. (2004b), Introduction: Promoting Global Health Through Biotechnology, Nature Biotechnology, 22(12s), DC3-DC7. Google Scholar öffnen DOI: 10.5771/9783845262321
  115. Times of India (2004), Novartis licences Torrent's AGE breaker molecule, 30.07.04. Google Scholar öffnen DOI: 10.5771/9783845262321
  116. Times of India (2010), Govt may limit FDI in pharma sector at 49%, 06.09.10. Google Scholar öffnen DOI: 10.5771/9783845262321
  117. Times of India (2012), PMO push for free drugs at govt hospitals, 13.02.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  118. Times of India (2013), Medicines Patent Pool and Roche tie up to increase access of key HIV drug, 05.08.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  119. Timmermans, Karin & Togi Hutadjulu (2000), Report, ASEAN Workshop on the TRIPs Agreement and its Impact on Pharmaceuticals, Jakarta, 02.-04. Mai. Google Scholar öffnen DOI: 10.5771/9783845262321
  120. Truffer, Bernhard, Harald Rohracher & Jochen Markard (2009), The Analysis of Institutions in Technological Innovation Systems - A Conceptual Framework Applied to Biogas Development in Austria, DRUID Summer Conference 2009, Copenhagen, 16.-20. Juni. Google Scholar öffnen DOI: 10.5771/9783845262321
  121. Tyfield, David (2008), Enabling TRIPs: The pharma-biotech-university patent coalition, Review of International Political Economy, 15(4), 535-566. Google Scholar öffnen DOI: 10.5771/9783845262321
  122. U.S. PIRG & Community Catalyst (2013), Top Twenty Pay-for-delay Drugs: How Drug Industry Payoffs Delay Generics, Inflate Prices and Hurt Consumers, July 2013. Google Scholar öffnen DOI: 10.5771/9783845262321
  123. UN (2012), The Millennium Development Goals Report 2012, New York: United Nations. Google Scholar öffnen DOI: 10.5771/9783845262321
  124. UNAIDS (2012), UNAIDS Report on the global AIDS epidemic, Geneva: Joint United Nations Programme on HIV/AIDS. Google Scholar öffnen DOI: 10.5771/9783845262321
  125. UNESCO (2010), UNESCO Science Report 2010: The Current Status of Science around the World, Paris. Google Scholar öffnen DOI: 10.5771/9783845262321
  126. Urias, Eduardo & João Furtado (2009), Institutional changes and their impacts on the Brazilian Pharmaceutical Industry: Is there an Innovation System on the way?, 7th GLOBELICS International Conference: Inclusive Growth, Innovation and Technological Change: education, social capital and sustainable development, Dakar, 06.-08. Oktober. Google Scholar öffnen DOI: 10.5771/9783845262321
  127. Van Dyck, Pooja (2007), Importing Western Style, Exporting Tragedy: Changes in Indian Patent Law and Their Impact on AIDS Treatment in Africa, North Western Journal of Technology and Intellectual Property, 6(1), 138-151. Google Scholar öffnen DOI: 10.5771/9783845262321
  128. Veembur, Arun (2004), CRO: Boom Time for India, Siliconindia,(June), 50-52. Google Scholar öffnen DOI: 10.5771/9783845262321
  129. Veloso, Francisco & Jorge Mario Soto (2001), Incentives, Infrastructure and Institutions: Perspectives on Industrialization and Technical Change in Late-Developing Nations, Technological Forecasting and Social Change, 66, 87-109. Google Scholar öffnen DOI: 10.5771/9783845262321
  130. Vieira, Fabiola Sulpino (2009), Ministry of Health's depending on drugs: program trends from 2002-2007, Revista de Saúde Pública, 43(4), 206-209. Google Scholar öffnen DOI: 10.5771/9783845262321
  131. Viotti, Eduardo B. (2002), National Learning Systems - A new approach on technological change in late industrializing economies and evidences from the cases of Brazil and South Korea, Technological Forecasting & Social Change, 69, 653-680. Google Scholar öffnen DOI: 10.5771/9783845262321
  132. von Alemann, Ulrich & Wolfgang Tönnesmann (1995), Grundriß: Methoden in der Politikwissenschaft, in: Ulrich von Alemann (Hrsg.), Politikwissenschaftliche Methoden: Grundriss für Studium und Forschung, Opladen: Westdeutscher Verlag, 17-140. Google Scholar öffnen DOI: 10.5771/9783845262321
  133. Wade, Robert (2003), What strategies are viable for developing countries today? The World Trade Organization and the shrinking of ‘development space’, Review of International Political Economy, 10(4), 621-644. Google Scholar öffnen DOI: 10.5771/9783845262321
  134. Walgenbach, Peter & Renate Meyer (2008), Neoinstitutionalistische Organisationstheorie, Suttgart: Kohlhammer. Google Scholar öffnen DOI: 10.5771/9783845262321
  135. Waning, Brenda, Ellen Diedrichsen & Suerie Moon (2010), A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries, Journal of the International AIDS Society, 13(35). Google Scholar öffnen DOI: 10.5771/9783845262321
  136. Westphal, Larry E., W. Rhee Yung & Garry Pursell (1984), Sources of Technological Capability in South Korea, in: Martin Fransman & Kenneth King (Hrsg.), Technological Capability in the Third World, London & Basingstoke: Macmillan, 279-300. Google Scholar öffnen DOI: 10.5771/9783845262321
  137. Wharton (2012), Sparring Over Sorafenib: How Will Natco’s Move against Bayer Affect Pharma Licensing?, Philadelphia: Knowledge@Wharton, The Wharton School, University of Pennsylvania, 19.04.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  138. Whitley, Richard (2000), Divergent Capitalisms: The Social Structuring and Change of Business Systems, Oxford: Oxford University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  139. WHO (2002), The Selection of Essential Medicines, WHO Policy Perspectives on Medicines, No. 4, Juni. Google Scholar öffnen DOI: 10.5771/9783845262321
  140. WHO (2003), New initiative to research and develop drugs for the world’s most neglected diseases, Delhi: World Health Organization, 25.06.03, <http://www. Google Scholar öffnen DOI: 10.5771/9783845262321
  141. who.int/mediacentre/news/releases/2003/pr51/en/#>. Google Scholar öffnen DOI: 10.5771/9783845262321
  142. WHO (2004a), Equitable access to essential medicines: a framework for collective action, WHO Policy Perspectives on Medicines, No. 8, Juni. Google Scholar öffnen DOI: 10.5771/9783845262321
  143. WHO (2004b), The World Medicines Situation, Geneva. Google Scholar öffnen DOI: 10.5771/9783845262321
  144. WHO (2011), Noncommunicable diseases, Fact sheet, Geneva, March 2013, <http://www.who.int/mediacentre/factsheets/fs355/en/#>. Google Scholar öffnen DOI: 10.5771/9783845262321
  145. WHO (2012), Defining Disease Types I, II AND III, Background document provided by the WHO Secretariat, Geneva: WHO Secretariat. Google Scholar öffnen DOI: 10.5771/9783845262321
  146. WHO (2013), World Health Statistics 2013, Geneva: WHO Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  147. WHO, WIPO & WTO (2012), Promoting Access to Medical Technologies and Innovation: Intersections between public health, intellectual property and trade, Geneva: World Health Organization, World Intellectual Property Organization and World Trade Organization. Google Scholar öffnen DOI: 10.5771/9783845262321
  148. Williamson, John (1989), What Washington Means by Policy Reform, in: John Williamson (Hrsg.), Latin American Adjustment: how much has happended?, Washington, D.C.: Institute for International Economics. Google Scholar öffnen DOI: 10.5771/9783845262321
  149. WIPO (2011), World Intellectual Property Report: The Changing Face of Innovation, WIPO Economics & Statistics Series, Geneva: World Intellectual Property Organization. Google Scholar öffnen DOI: 10.5771/9783845262321
  150. World Bank (2002), World Development Report 2002: Building Institutions for Markets, New York: Oxford University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  151. World Bank (2009), World Development Report 2009: Reshaping Economic Geography, Washington, D.C.: The World Bank. Google Scholar öffnen DOI: 10.5771/9783845262321
  152. World Bank (2010), Investing Across Borders 2010: Indicators of foreign direct investment regulation in 87 countries, Washington, D.C.: The World Bank Group. Google Scholar öffnen DOI: 10.5771/9783845262321
  153. Wright, Alan (2008), Innovation in Brazil: Public Policies and Business Strategies, March 2008, Washington, D.C.: Woodrow Wilson Center for Scholars, Brazil Institute and the Program on Science, Technology, America and The Global Economy. Google Scholar öffnen DOI: 10.5771/9783845262321
  154. Yeats, Alexander J. (2001), Just How Big is Global Production Sharing?, in: Sven W. Arndt & Henryk Kierzkowski (Hrsg.), Fragmentation: new production patterns in the world economy, Oxford: Oxford University Press, 108-143. Google Scholar öffnen DOI: 10.5771/9783845262321
  155. Young, Terry A. (2010), The Rise of Intellectual Property and Incubation in India, Beyond the First World, 1(8). Google Scholar öffnen DOI: 10.5771/9783845262321
  156. Zanatta, Mariana et al. (2008), National policies to attract FDI in R&D: An assessment of Brazil and selected countries, Research Paper, No. 69, Helsinki: United Nations University, World Institute for Development Economic Research . Google Scholar öffnen DOI: 10.5771/9783845262321
  157. Abbott, Frederick M. (2005), The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of Public Health, American Journal of International Law, 99(2), 317-358. Google Scholar öffnen DOI: 10.5771/9783845262321
  158. Abramovitz, Moses (1986), Catching Up, Forging Ahead, and Falling Behind, Journal of Economic History, 46(2), 385-406. Google Scholar öffnen DOI: 10.5771/9783845262321
  159. Abrol, Dinesh (2004), Post-TRIPS Technological Behaviour of the Pharmaceutical Industry in India, Science, Technology & Society, 9(2), 243-271. Google Scholar öffnen DOI: 10.5771/9783845262321
  160. Abrol, Dinesh, Pramod Prajapati & Nidhi Singh (2010), Globalization of the Indian pharmaceutical industry: Implications for the direction, distribution and diversity in drug innovation, 8th GLOBELICS International Conference: Making Innovation Work for Society - Linking, Leveraging and Learning, Kuala Lumpur, 01.-03. November. Google Scholar öffnen DOI: 10.5771/9783845262321
  161. Abrol, Dinesh, Pramod Prajapati & Nidhi Singh (2011), Globalization of the Indian Pharmaceutical Industry: Implications for Innovation, International Journal of Institutions and Economies, 3(2), 327-365. Google Scholar öffnen DOI: 10.5771/9783845262321
  162. Abromeit, Heidrun & Michael Stoiber (2006), Demokratien im Vergleich: Einführung in die vergleichende Analyse politischer Systeme, Wiesbaden: VS Verlag für Sozialwissenschaften. Google Scholar öffnen DOI: 10.5771/9783845262321
  163. Adeoti, John Olatunji (2002), Building technological capability in the less developed countries: the role of a national system of innovation, Science and Public Policy, 29(2), 95-104. Google Scholar öffnen DOI: 10.5771/9783845262321
  164. Adler, Emanuel (1988), State Institutions, Ideology, and Autonomous Technological Development: Computers and Nuclear Energy in Argentina and Brazil, Latin American Research Review, 23(2), 59-90. Google Scholar öffnen DOI: 10.5771/9783845262321
  165. Agência Saúde (2011), Saúde Não Tem Preço: Acesso a medicamentos gratuitos triplica no país, Ministério da Saúde, 13.09.2011. Google Scholar öffnen DOI: 10.5771/9783845262321
  166. Agência Saúde (2013), Ministério da Saúde vai investir R$ 35 bi até 2016 na compra de medicamentos produzidos no País, 23. April, <http://portalsaude.saude.gov.br/portalsaude/impressao/10405/162/ministerio-da-saude-vai-investir-r$-35-bi-ate-2016.html>. Google Scholar öffnen DOI: 10.5771/9783845262321
  167. Aggarwal, Aradhna (2004), Strategic Approach to Strengthening the International Competitiveness in Knowledge Based Industries: The Indian Pharmaceutical Industry, RIS Discussion Paper, 80/2004, New Delhi: Research and Information System for the Non-Aligned and Other Developing Countries. Google Scholar öffnen DOI: 10.5771/9783845262321
  168. Aggarwal, Aradhna (2006), Liberalisation, Technology Policies and Acquisition of Technological Capabilities: A Study of Indian Industry, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen DOI: 10.5771/9783845262321
  169. AGU (2010), Parecer No. 337 /PGF/EA/2010, Brasília: Advocacia-Geral da União Procuradoria-Geral Federal, 04. März. Google Scholar öffnen DOI: 10.5771/9783845262321
  170. Alger, Jackeline et al. (2009), National health research systems in Latin America: a 14-country review, Pan American Journal of Public Health, 26(5), 447-457. Google Scholar öffnen DOI: 10.5771/9783845262321
  171. Altenburg, Tilman (2006), Governance Patterns in Value Chains and their Development Impact, The European Journal of Development Research, 18(4), 498-521. Google Scholar öffnen DOI: 10.5771/9783845262321
  172. Altenburg, Tilman (2009), Building inclusive innovation systems in developing countries: challenges for IS research, in: Bengt-Åke Lundvall et al. (Hrsg.), Handbook of Innovation Systems and Developing Countries: Building Domestic Capabilities in a Global Setting, Cheltenham: Edward Elgar, 33-56. Google Scholar öffnen DOI: 10.5771/9783845262321
  173. Amable, Bruno (2000), Institutional Complementarity and Diversity of Social Systems of Innovation and Production, Review of International Political Economy, 7(4), 645-687. Google Scholar öffnen DOI: 10.5771/9783845262321
  174. Amann, Edmund (2000), Economic Liberalization and Industrial Performance in Brazil, Oxford: Oxford University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  175. Amighini, Alessia (2006), Upgrading in International Trade: Methods and Evidence from Selected Sectors in Latin America, in: Carlo Pietrobelli & Roberta Rabellotti (Hrsg.), Upgrading to Compete: Global Value Chains, Clusters, and SMEs in Latin America, Washington, D.C.: Inter-American Development Bank, 221-250. Google Scholar öffnen DOI: 10.5771/9783845262321
  176. Amin, Tahir (2007), Voluntary Licensing Practices in the Pharmaceutical Sector: An Acceptable Solution to Improving Access to Affordable Medicines?, Initiative For Medicines, Access & Knowledge, 08.02.07. Google Scholar öffnen DOI: 10.5771/9783845262321
  177. Amsden, Alice H. (1989), Asia’s Next Giant: South Korea and Late Industrialization, Oxford: Oxford University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  178. Anderson, Warwick H. (2002), Postcolonial technoscience, Social Studies of Science, 32(5-6), 643-658. Google Scholar öffnen DOI: 10.5771/9783845262321
  179. AnproTec (2008), Portfolio de Parques Tecnológicos no Brasil, Brasília: Associação Nacional de Entidades Promotoras de Empreendimentos Inovadores, Dezember 2008. Google Scholar öffnen DOI: 10.5771/9783845262321
  180. Årdal, Christine (2012), Open Source Drug Discovery in Practice: A Case Study, PLOS Neglected Tropical Diseases, 6(9), 1-11. Google Scholar öffnen DOI: 10.5771/9783845262321
  181. Arndt, Sven W. & Henryk Kierzkowski (2001), Introduction, in: Sven W. Arndt & Henryk Kierzkowski (Hrsg.), Fragmentation: new production patterns in the world economy, Oxford: Oxford University Press, 1-16. Google Scholar öffnen DOI: 10.5771/9783845262321
  182. Arocena, Rodrigo & Judith Sutz (2000), Looking at National Systems of Innovation from the South, Industry and Innovation, 7(1), 55-75. Google Scholar öffnen DOI: 10.5771/9783845262321
  183. Asheim, Bjorn (2007), Differentiated Knowledge Bases and Varieties of Regional Innovation Systems, Innovation: The European Journal of Social Science Research, 20(3), 223-241. Google Scholar öffnen DOI: 10.5771/9783845262321
  184. Ashford, Nicholas A. & Ralph P. Hall (2011), Technology, Globalization, and Sustainable Development: Transforming the Industrial State, New Haven: Yale University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  185. ATX-BA (2012), A ATX-BA Parabeniza a Bahiafarma e a Novartis Pela Iniciativa em Prol Dos Pacientes Transplantados, <http://atxbahia.blogspot.de/2012/12/ Google Scholar öffnen DOI: 10.5771/9783845262321
  186. a-atx-ba-parabeniza-bahiafarma-e.html>. Google Scholar öffnen DOI: 10.5771/9783845262321
  187. Avila, Jorge (2008), Patentes Farmacêuticas no Brasil, 2° Encontro Nacional de Inovação em Fármacos e Medicamentos, Sao Paolo, 12.-13. November. Google Scholar öffnen DOI: 10.5771/9783845262321
  188. Ayyaswamy, Jancy, Neeraj Saxena & Antaryami Parida (2010), Government mediated program on intensifying industry- academia linkages for human resource development; Experiences of an innovative model from TIFAC, Forecasting & Assessment Council (TIFAC) Technology Information. Google Scholar öffnen DOI: 10.5771/9783845262321
  189. Bae, Zong-Tae & Jin-woo Chung (2001), The Impact of External Environment and Technological Learning System on the Relationship Between Technological Alliance and Performance of Korean Small Telecom Firms, Portland International Conference on Management of Engineering and Technology, Portland, 29.07.-02.08. Google Scholar öffnen DOI: 10.5771/9783845262321
  190. Bakhru, Girish & Nam Park (2013), India Pharmaceuticals: Generics are evolving, Mumbai: HSBC Global Research, Juni 2013. Google Scholar öffnen DOI: 10.5771/9783845262321
  191. Baković, Tomislav (2010), Managing innovation systems in transition economies, FEB-Zg working papers, 10-01, Zagreb: Faculty of Economics and Business, The University of Zagreb. Google Scholar öffnen DOI: 10.5771/9783845262321
  192. Balzat, Markus & Horst Hanusch (2004), Recent Trends in the Research on National Innovation Systems, Journal of Evolutionary Economics, 14(2), 197-210. Google Scholar öffnen DOI: 10.5771/9783845262321
  193. Barton, John et al. (2002), Integrating Intellectual Property Rights and Development Policy, Report of the Commission on Intellectual Property Rights, London: Commission on Intellectual Property Rights. Google Scholar öffnen DOI: 10.5771/9783845262321
  194. Basant, Rakesh (2006), Intellectual Property Rights Regime and Creation of Innovation based Enterprises in India, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen DOI: 10.5771/9783845262321
  195. Baskaran, Angathevar & Rebecca Boden (2006), Knowledge Capital and Globalisation: Towards a new Conceptual Model, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen DOI: 10.5771/9783845262321
  196. Bassala, George (1967), The Spread of Western Science, Science, 156(3775), 611-622. Google Scholar öffnen DOI: 10.5771/9783845262321
  197. Bastos, Maria Ines (1994), How international sanctions worked: Domestic and foreign political constraints on the Brazilian informatics policy, Journal of Development Studies, 30(2), 380-404. Google Scholar öffnen DOI: 10.5771/9783845262321
  198. Bastos, Valéria Delgado (2005), Inovação Farmacêutica: Padrão Setorial e Perspectivas para o Caso Brasileiro, BNDES Setorial, 22, 271-296. Google Scholar öffnen DOI: 10.5771/9783845262321
  199. Bazan, Luiza & Lizbeth Navas-Aleman (2004), The underground revolution in the Sinos Valley: a comparison of upgrading in global and national value chains, in: Hubert Schmitz (Hrsg.), Local Enterprises in the Global Economy: issues of governance and upgrading Cheltenham: Edward Elgar, 110-139. Google Scholar öffnen DOI: 10.5771/9783845262321
  200. BBC News (2004), Brazil to break Aids drug patents, 01.12.04. Google Scholar öffnen DOI: 10.5771/9783845262321
  201. Bell, Martin (1984), 'Learning' and the Accumulation of Industrial Technological Capacity in Developing Countries, in: Martin Fransman & Kenneth King (Hrsg.), Technological Capability in the Third World, London: Macmillan, 187-209. Google Scholar öffnen DOI: 10.5771/9783845262321
  202. Bell, Martin & Keith Pavitt (1993), Technological Accumulation and Industrial Growth: Contrasts Between Developed and Developing Countries, Industrial and Corporate Change, 2(2), 157-210. Google Scholar öffnen DOI: 10.5771/9783845262321
  203. Bessen, James & Michael Meurer (2008), Patent Failure: How Judges, Bureaucrats, and Lawyers Put Innovators at Risk, Princeton: Princeton University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  204. Bhardwaj, Anshu, Vinod Scaria & Deblina Patra (2011), Open Source Drug Discovery: A Global Collaborative Drug Discovery Model for Tuberculosis, Science and Culture, 77(1-2), 22-26. Google Scholar öffnen DOI: 10.5771/9783845262321
  205. Bhattacharya, Radhika (2008), Are Developing Countries Going Too Far on Trips? A Closer Look at The new Laws in India, American Journal of Law and Medicine, 34(2-3), 395-421. Google Scholar öffnen DOI: 10.5771/9783845262321
  206. Bhattacharya, Sujit (2006), Harmonization of Patent Rules and Regulations and its Plausible Implications in Developing Countries: A Case Study of India, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen DOI: 10.5771/9783845262321
  207. Bhojwani, Hiro (2005), Developing Innovative Capacity in India to Meet Health Needs, in: Ingrid Hering (Hrsg.), Innovation in Developing Countries to Meet Health Needs: Experiences of China, Brazil, South Africa and India, Oxford: The Centre for Management of IP in Health R&D, 112-153. Google Scholar öffnen DOI: 10.5771/9783845262321
  208. Bianchi Pagola, Carlos F. (2012), O papel das políticas públicas no regime de inovação de biotecnologia para saúde humana: Brasil 2002-2010, Tese de Doutorado, Rio de Janeiro: Instituto de Economia da Universidade Federal do Rio de Janeiro. Google Scholar öffnen DOI: 10.5771/9783845262321
  209. Bidwai, Praful (1995), One Step Forward, Many Steps Back: Dismemberment of India’s National Drug Policy, Development Dialogue, 1995(1), 193-222. Google Scholar öffnen DOI: 10.5771/9783845262321
  210. Bierly, P.E. III & A.K. Chakrabarti (1996), Technological learning, strategic flexibility, and new product development in the pharmaceutical industry, IEEE Transactions on Engineering Management, 43(4), 368-380. Google Scholar öffnen DOI: 10.5771/9783845262321
  211. Biocon (2010), Biocon Biopharmaceuticals Private Limited becomes wholly owned subsidiary of Biocon, 05. April, <http://www.biocon.com/biocon_press_release_ Google Scholar öffnen DOI: 10.5771/9783845262321
  212. details.asp?subLink=news&Fileid=384>. Google Scholar öffnen DOI: 10.5771/9783845262321
  213. Biocon (2012), Biocon announces that it has entered into an option agreement with Bristol-Myers Squibb for Biocon’s IN-105, an oral insulin drug candidate, 16. November, <http://www.biocon.com/biocon_inv_press_releases_16112012.asp>. Google Scholar öffnen DOI: 10.5771/9783845262321
  214. Bird, Robert & Daniel R. Cahoy (2008), The Impact of Compulsory Licensing on Foreign Direct Investment: A Collective Bargaining Approach, American Business Law Journal, 45(2), 283-330. Google Scholar öffnen DOI: 10.5771/9783845262321
  215. Bloch, Harry (Hrsg.) (2003), Growth and development in the global economy, Cheltenham: Edward Elgar. Google Scholar öffnen DOI: 10.5771/9783845262321
  216. Blomstrom, Magnus, Robert E. Lipsey & Mario Zejan (1992), What explains developing country growth?, NBER Working Paper Series, No. 4132, Cambridge: National Bureau of Economic Research. Google Scholar öffnen DOI: 10.5771/9783845262321
  217. Bloomberg Businessweek (2013), Dr. Reddy's Laboratories, <http://investing. Google Scholar öffnen DOI: 10.5771/9783845262321
  218. businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=DRRD:IN>. Google Scholar öffnen DOI: 10.5771/9783845262321
  219. BMI (2011), Roche Signs Technology-Transfer Deal With Government-Run Drugmaker, Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions, Business Monitor International, April. Google Scholar öffnen DOI: 10.5771/9783845262321
  220. BMI (2012a), DSM To Manufacture Recepta's Antibodies, News and analysis on global M&A and corporate financing strategies, Business Monitor International, Juli. Google Scholar öffnen DOI: 10.5771/9783845262321
  221. BMI (2012b), New Joint Ventures Between Multinationals And Local Drugmakers, News and analysis on global M&A and corporate financing strategies, Business Monitor International, Februar. Google Scholar öffnen DOI: 10.5771/9783845262321
  222. BMI (2012c), Pharmaceutical Trade Surplus To Widen, Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions, Business Monitor International, März 2012. Google Scholar öffnen DOI: 10.5771/9783845262321
  223. Börzel, Tanja A. (2008), Der "Schatten der Hierarchie" — Ein Governance-Paradox?, in: Gunnar Folke Schuppert & Michael Zürn (Hrsg.), Governance in einer sich wandelnden Welt, Wiesbaden: VS Verlag für Sozialwissenschaften, 118-131. Google Scholar öffnen DOI: 10.5771/9783845262321
  224. Botzem, Sebastian (2002), Governance-Ansätze in der Steuerungsdiskussion: Steuerung und Selbstregulierung unter den Bedingungen fortschreitender Internationalisierung Discussion Paper, FS I 02 -106, Berlin: Wissenschaftszentrum Berlin für Sozialforschung,. Google Scholar öffnen DOI: 10.5771/9783845262321
  225. Bower, D. Jane & Julian C. Sulej (2007), The Indian Challenge: The Evolution of a Successful New Global Strategy in the Pharmaceutical Industry, Technology Analysis & Strategic Management, 19(5), 611-624. Google Scholar öffnen DOI: 10.5771/9783845262321
  226. Braczyk, Hans-Joachim, Philip Cooke & Martin Heidenreich (Hrsg.) (1998), Regional Innovation Systems: The role of governances in a globalized world, London: UCL Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  227. Brooks, Sarah M. (2004), Explaining Capital Account Liberalization in Latin America: A Transitional Cost Approach, World Politics, 56(3), 389-430. Google Scholar öffnen DOI: 10.5771/9783845262321
  228. Bruton, Henry (1989), Import Substitution, in: Hollis Chenery & T.N. Srinivasan (Hrsg.), Handbook of Development Economics, 2, Amsterdam: Elsevier, 1601-1644. Google Scholar öffnen DOI: 10.5771/9783845262321
  229. Business Standard (2004a), Biocon denies deaths in trials, 24.08.04. Google Scholar öffnen DOI: 10.5771/9783845262321
  230. Business Standard (2004b), Syngene in research deal with Novartis, 01.09.04. Google Scholar öffnen DOI: 10.5771/9783845262321
  231. Business Standard (2005), Glenmark, Teijin announce $53mn deal, Mumbai, April 26, 2005. Google Scholar öffnen DOI: 10.5771/9783845262321
  232. Business Standard (2009), Lupin out-licenses drug to US major Salix, 06.10.09. Google Scholar öffnen DOI: 10.5771/9783845262321
  233. Business Standard (2012), Pharma majors named in clinical trial death list, 24.07.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  234. BusinessWire (2007), Merck & Co., Inc. Statement on Brazilian Government's Decision To Issue Compulsory License for STOCRIN, 04.05.07. Google Scholar öffnen DOI: 10.5771/9783845262321
  235. BusinessWire (2010), Dr. Reddy's and Rheoscience Announce Headline Results from First Phase III Clinical Trial of Balaglitazone (DRF 2593), 04.01.10. Google Scholar öffnen DOI: 10.5771/9783845262321
  236. Businessworld (2010), Death of a Dream, 08.02.10, <http://www.businessworld.in/ Google Scholar öffnen DOI: 10.5771/9783845262321
  237. news/business/pharma/death-of-a-dream/460435/page-1.html>. Google Scholar öffnen DOI: 10.5771/9783845262321
  238. Cadila Healthcare (2013), Zydus pioneers a breakthrough with LIPAGLYN, India’s first NCE to reach the market, 05.06.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  239. Caliari, Thiago & Ricardo Ruiz (2010), Structure and Innovation in Pharmaceutical Industry in Brazil: The Impact of Generic Drugs, DRUID-DIME Academy Winter Conference 2010, Aalborg, 21.-23. Januar. Google Scholar öffnen DOI: 10.5771/9783845262321
  240. Campos, Claudio Maggi (2006), The Salmon Farming and Processing Cluster in Southern Chile, in: Carlo Pietrobelli & Roberta Rabellotti (Hrsg.), Upgrading to Compete: Global Value Chains, Clusters, and SMEs in Latin America, Washington, D.C.: Inter-American Development Bank, 109-140. Google Scholar öffnen DOI: 10.5771/9783845262321
  241. Casas, Carmen Nila Phang Romero (2009), O complexo industrial da saúde na área farmacêutica: uma discussão sobre inovação e acesso no Brasil, Tese apresentada com vistas à obtenção do título de Doutor em Ciências na área de Saúde Pública, Rio de Janeiro: Escola Nacional de Saúde Pública. Google Scholar öffnen DOI: 10.5771/9783845262321
  242. Cassier, Maurice (2013), Pharmaceutical Patent Law In-the-Making: Opposition and Legal Action by States, Citizens, and Generics Laboratories in Brazil and India, in: Jean-Paul Gaudillière & Volker Hess (Hrsg.), Ways of Regulating Drugs in the 19th and 20th Centuries, Basingstoke: Palgrave Macmillan. Google Scholar öffnen DOI: 10.5771/9783845262321
  243. Cassier, Maurice & Carlos Correa (2003), Patents, Innovation and Public Health: Brazilian Public-Sector Laboratories’ Experience in Copying AIDS Drugs, in: Jean-Paul Moatti et al. (Hrsg.), Economics of AIDS and Access to HIV/AIDS Care in Developing Countries: Issues and Challenges, Paris: ANRS, Collection Sciences Sociales et Sida, 89-107. Google Scholar öffnen DOI: 10.5771/9783845262321
  244. Cassier, Maurice & Carlos Correa (2008), Scaling-up and reverse engineering: acquisition of industrial knowledge by copying drugs in Brazil, in: Benjamin Coriat (Hrsg.), The Political Economy of HIV/AIDS in Developing Countries: TRIPS, Public Health Systems and Free Access, Cheltenham: Edward Elgar, 130-149. Google Scholar öffnen DOI: 10.5771/9783845262321
  245. Cassier, Maurice & Marilena Correa (2007), Intellectual Property and Public Health: Coping of HIV/aids drugs by Brazilian public and private pharmaceutical laboratories, Electronic Journal of Communication, Information and Innovation in Health, 1(1), 83-90. Google Scholar öffnen DOI: 10.5771/9783845262321
  246. Cechinel-Filho, Valdir (Hrsg.) (2012), Plant Bioactives and Drug Discovery: Principles, Practice, and Perspectives, Hoboken: Wiley. Google Scholar öffnen DOI: 10.5771/9783845262321
  247. Centad (2010), Competition Law and Indian Pharmaceutical Industry, New Delhi: Centre for Trade and Development. Google Scholar öffnen DOI: 10.5771/9783845262321
  248. Chadha, Alka (2009), TRIPs and patenting activity: Evidence from the Indian pharmaceutical industry, Economic Modelling, 26(2), 499-505. Google Scholar öffnen DOI: 10.5771/9783845262321
  249. Chagti, Anuradha Sharma (2007), Intellectual Property Rights and Development: Strategies for Developing Countries, Journal of Development and Social Transformation, 3, 27-35. Google Scholar öffnen DOI: 10.5771/9783845262321
  250. Chamas, Claudia Ines (2005), Developing Innovative Capacity in Brazil to meet Health Needs, in: Ingrid Hering (Hrsg.), Innovation in Developing Countries to Meet Health Needs: Experiences of China, Brazil, South Africa and India, Oxford: The Centre for Management of IP in Health R&D, 75-111. Google Scholar öffnen DOI: 10.5771/9783845262321
  251. Chamber of Deputies (2013), Brazil's Patent Reform: Innovation Towards National Competitiveness, Brasília: Chamber of Deputies, Center for Strategic Studies and Debates. Google Scholar öffnen DOI: 10.5771/9783845262321
  252. Chang, Ha-Joon (2002), Kicking Away the Ladder: Development Strategy in Historical Perspective, London: Anthem Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  253. Chataway, Joanna et al. (2007), Building the Case for National Systems of Health Innovation, A Background Policy Paper prepared for NEPAD in advance of the AMCOST meeting and the African Union Summit, Pretoria: NEPAD. Google Scholar öffnen DOI: 10.5771/9783845262321
  254. Chataway, Joanna, Dinar Kale & David Wield (2007), The Indian Pharmaceutical Industry Before and After Trips, Technology Analysis & Strategic Management, 19(5), 559-563. Google Scholar öffnen DOI: 10.5771/9783845262321
  255. Chataway, Joanna, Joyce Tait & David Wield (2007), Frameworks for Pharmaceutical Innovation in Developing Countries: The Case of Indian pharma, Technology Analysis and Strategic Management, 19(5), 697-708. Google Scholar öffnen DOI: 10.5771/9783845262321
  256. Chaturvedi, Kalpana & Joanna Chataway (2006), Innovation in the Post-TRIPs Regime in Indian Pharmaceutical Firms: Implications for Pharmaceutical Model, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen DOI: 10.5771/9783845262321
  257. Chaturvedi, Kalpana, Joanna Chataway & David Wield (2007), Policy, Markets and Knowledge: Strategic Synergies in Indian Pharmaceutical Firms, Technology Analysis & Strategic Management, 19(5), 565-588. Google Scholar öffnen DOI: 10.5771/9783845262321
  258. Chaudhuri, Sudip (1984), Manufacturing Drugs without TNCs: Status of Indigenous Sector in India, Economic & Political Weekly, 19(30), 1341-1383. Google Scholar öffnen DOI: 10.5771/9783845262321
  259. Chaudhuri, Sudip (2005), The WTO and India's Pharmaceuticals Industry: Patent Protection, TRIPS, and Developing Countries, Oxford: Oxford University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  260. Chaudhuri, Sudip (2008), Is Product Patent Protection Necessary to Spur Innovation in Developing Countries?, in: Neil Weinstock Netanel (Hrsg.), The Development Agenda, Global Intellectual Property and Developing Countries, New York: Oxford University Press, 265-292. Google Scholar öffnen DOI: 10.5771/9783845262321
  261. Chaudhuri, Sudip (2007), The Gap Between Successful Innovation and Access to its Benefits: Indian Pharmaceuticals, The European Journal of Development Research, 19(1), 49-65. Google Scholar öffnen DOI: 10.5771/9783845262321
  262. Chaves, Gabriela Costa & Maria Auxiliadora Oliveira (2007), Measuring the degree of public health sensitivity of patent legislation in the context of the WTO TRIPS Agreement, Bulletin of the World Health Organization, 85(1), 49-56. Google Scholar öffnen DOI: 10.5771/9783845262321
  263. Chaves, Gabriela Costa, Marcela Fogaça Vieira & Renata Reis (2008), Access to medicines and intellectual property in Brazil: reflections and strategies of civil society, Sur – Revista Internacional de Direitos Humanos, 5(8), 163-189. Google Scholar öffnen DOI: 10.5771/9783845262321
  264. Choung, Jae-Yong, Hye-Ran Hwang & Jin-Ho Choi (2000), Transition of Latecomer Firms from Technology Users to Technology Generators: Korean Semiconductor Firms, World Development, 28(5), 969-982. Google Scholar öffnen DOI: 10.5771/9783845262321
  265. Cimoli, Mario & Gabriel Porcile (2009), Sources of learning paths and technological capabilities: an introductory roadmap of development processes, Economics of Innovation and New Technology, 18(7), 675-694. Google Scholar öffnen DOI: 10.5771/9783845262321
  266. Clinton Health Access Initiative (2013), ARV Ceiling Price List (August 2013), <http://www.clintonhealthaccess.org/news-and-information/ Google Scholar öffnen DOI: 10.5771/9783845262321
  267. ARV-Ceiling-Price-List-May-2013>. Google Scholar öffnen DOI: 10.5771/9783845262321
  268. CNCTIS (2004), 2ª Conferência Nacional de Ciência, Tecnologia e Inovação em Saúde, Brasília: Ministério da Saúde. Google Scholar öffnen DOI: 10.5771/9783845262321
  269. CNS (2004), Resolução No. 338, de 6 de Maio de 2004, Diário Oficial da União - Seção 1, Brasília: Conselho Nacional de Saúde. Google Scholar öffnen DOI: 10.5771/9783845262321
  270. Coe, Neil M. & Timothy G. Bunnell (2003), ‘Spatializing’ knowledge communities: towards a conceptualization of transnational innovation networks, Global Networks, 3(4), 437-456. Google Scholar öffnen DOI: 10.5771/9783845262321
  271. Cohen, Jillian Clare (2006), Expanding Drug Access in Brazil, Canadian Journal of Public Health, 97(6), 15-18. Google Scholar öffnen DOI: 10.5771/9783845262321
  272. Cohen, Jillian Clare & Kristina M. Lybecker (2005), Aids Policy and Pharmaceutical Patents: Brazil's Strategy to Safeguard Public Health, The World Economy, 28(2), 211-230. Google Scholar öffnen DOI: 10.5771/9783845262321
  273. Cohen, Wesley M. & Daniel A. Levinthal (1990), Absorptive Capacity: A New Perspective on Learning and Innovation, Administrative Science Quarterly, 35(1), 128-152. Google Scholar öffnen DOI: 10.5771/9783845262321
  274. Cooke, Philip (1993), Regional innovation networks: An evaluation of six European cases, Topos, 6, 1-30. Google Scholar öffnen DOI: 10.5771/9783845262321
  275. Cooke, Philip (1998), Introduction: Origins of the Concept, in: Hans-Joachim Braczyk et al. (Hrsg.), Regional Innovation Systems: The role of governances in a globalized world, London: UCL Press, 2-25. Google Scholar öffnen DOI: 10.5771/9783845262321
  276. Coombs, Rod, Paolo Saviotti & Vivien Walsh (Hrsg.) (1992), Technical change and company strategies: economic and sociological perspectives, London: Academy Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  277. Coriat, Benjamin & Olivier Weinstein (2002), Organizations, firms and institutions in the generation of innovation, Research Policy, 31(2), 273-290. Google Scholar öffnen DOI: 10.5771/9783845262321
  278. Coriat, Benjamin & Olivier Weinstein (2012), Patent regimes, firms and the commodification of knowledge, Socio-Economic Review, 10(2), 267-292. Google Scholar öffnen DOI: 10.5771/9783845262321
  279. Correa, Carlos M. (2011), Pharmaceutical Innovation, Incremental Patenting and Compulsory Licensing, South Centre Research Paper, No. 41, Geneva: South Centre,. Google Scholar öffnen DOI: 10.5771/9783845262321
  280. Costa, Laís Silveira, Carlos Augusto Grabois Gadelha & Antoine Metten (2012), Saúde e Desenvolvimento no Brasil: estado da arte e desafios, Resumo aprovado para apresentação pôster na VI Jornada Nacional de Economica da Saúde, Brasília, 17.-19. Oktober. Google Scholar öffnen DOI: 10.5771/9783845262321
  281. Costinot, Arnaud (2009), An Elementary Theory of Comparative Advantage, NBER Working Paper, No. 14645, Cambridge: National Bureau of Economic Research. Google Scholar öffnen DOI: 10.5771/9783845262321
  282. Cozzens, Susan E. & Raphael Kaplinsky (2009), Innovation, poverty and inequality: cause, coincidence, or co-evolution?, in: Bengt-Åke Lundvall et al. (Hrsg.), Handbook of Innovation Systems and Developing Countries: Building Domestic Capabilities in a Global Setting, Cheltenham: Edward Elgar, 57-82. Google Scholar öffnen DOI: 10.5771/9783845262321
  283. Cozzens, Susan, Sonia Gatchair & Dhanaraj Thakur (2006), Distributional Assessment of Emerging Technologies: A Framework Analysis, James Martin Institute Working Paper, 1. Google Scholar öffnen DOI: 10.5771/9783845262321
  284. Creswell, John W. (2003), Research Design: Qualitative, Quantitative, and Mixed Methods Approaches, Thousand Oaks: Sage. Google Scholar öffnen DOI: 10.5771/9783845262321
  285. CSDD (2010), Outlook 2010, Boston: Tufts Center for the Study of Drug Development. Google Scholar öffnen DOI: 10.5771/9783845262321
  286. Cullet, Philippe (2001), Patents Bill, TRIPs and Right to Health, Economic & Political Weekly, 36(43), 4049-4051. Google Scholar öffnen DOI: 10.5771/9783845262321
  287. D'Mello, Bernard (2002), Transnational Pharmaceutical Corporations and Neo-Liberal Business Ethics in India, Journal of Business Ethics, 36(1-2), 165-185. Google Scholar öffnen DOI: 10.5771/9783845262321
  288. Da Gama Camara Jr, Eduardo (2013), Brazil: Prosecution Of Pharmaceutical Patents In Brazil: Tensions Between The Brazilian Patent Office And ANVISA, <http://www.mondaq.com/article.asp?articleid=253068>. Google Scholar öffnen DOI: 10.5771/9783845262321
  289. Dahlmann, Carl (2010), Innovation Strategies in Brazil, China and India: From Imitation to Deepening Technological Capability in the South, in: Xiaolan Fu & Luc Soete (Hrsg.), The Rise of Technological Power in the South, Basingstoke: Palgrave Macmillan, 15-48. Google Scholar öffnen DOI: 10.5771/9783845262321
  290. Damodaran, A. (2008), Indian Patent Law in the post-TRIPS Decade: S & T Policy Appraisal, Journal of Intellectual Property Rights, 13, 414-423. Google Scholar öffnen DOI: 10.5771/9783845262321
  291. Datta, P. T. Jyothi (2013), Health Ministry scrambles to procure TB drugs, The Hindu Business Line, 23.06.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  292. David, Paul A. & Dominique Foray (2002), An introduction to the economy of the knowledge society, International Social Science Journal, 54(171), 9-23. Google Scholar öffnen DOI: 10.5771/9783845262321
  293. Davies, Louise (2002), Technical Cooperation and the International Coordination of Patentability of Biotechnological Inventions, Journal of Law and Society, 29(1), 137-162. Google Scholar öffnen DOI: 10.5771/9783845262321
  294. de Brito Cruz, Carlos Henrique & Hernan Chaimovich (2010), Brazil, in: Susan Schneegans (Hrsg.), UNESCO Science Report 2010, Paris: UNESCO Publishing, 103-121. Google Scholar öffnen DOI: 10.5771/9783845262321
  295. de Brito Cruz, Carlos Henrique & Luiz de Mello (2006), Boosting Innovation Performance in Brazil, OECD Economics Department Working Papers, No. 532, Paris: OECD Publishing. Google Scholar öffnen DOI: 10.5771/9783845262321
  296. De La Rosa, Sybille & Matthias Kötter (2008), Governance(-forschung) im Kontext der Disziplinen, in: Sybille De La Rosa et al. (Hrsg.), Transdisziplinäre Governanceforschung: Gemeinsam hinter den Staat blicken, Baden-Baden: Nomos, 11-33. Google Scholar öffnen DOI: 10.5771/9783845262321
  297. Deardoff, Alan V. (1992), Welfare Effects of Global Patent Protection, Economica, 59(233), 35-51. Google Scholar öffnen DOI: 10.5771/9783845262321
  298. DGVN (2011), Nachhaltigkeit und Gerechtigkeit: Eine bessere Zukunft für alle, Bericht über die menschliche Entwicklung 2011, Berlin: Deutsche Gesellschaft für die Vereinten Nationen. Google Scholar öffnen DOI: 10.5771/9783845262321
  299. Di Giorgio, Rosana Ceron (2007), From University to Industry: Technology Transfer at Unicamp in Brazil, in: Anatole Krattiger et al. (Hrsg.), Intellectual Property Management in Health and Agricultural Innovation: a handbook of best practices, Oxford: MIHR, 1747-1752. Google Scholar öffnen DOI: 10.5771/9783845262321
  300. Diário da Saúde (2010), Brasil produzirá medicamento biotecnológico para doença de Gaucher, <http://www.diariodasaude.com.br/news.php?article= Google Scholar öffnen DOI: 10.5771/9783845262321
  301. remedio-doenca-gaucher&id=5790>. Google Scholar öffnen DOI: 10.5771/9783845262321
  302. Dicken, Peter (2003), Global Shift: Reshaping the Global Economic Map in the 21st Century, London: Sage. Google Scholar öffnen DOI: 10.5771/9783845262321
  303. Dicken, Peter et al. (2001), Chains and networks, territories and scales: towards a relational framework for analysing the global economy, Global Networks, 1(2), 89-112. Google Scholar öffnen DOI: 10.5771/9783845262321
  304. DIPP (2010), Discussion Paper: Compulsory Licencing, Department of Industrial Policy & Promotion, Government of India, Ministry of Commerce & Industry, New Delhi. Google Scholar öffnen DOI: 10.5771/9783845262321
  305. DIPP (2013), SIA Newsletter February 2013, Department of Industrial Policy & Promotion, Government of India, Ministry of Commerce & Industry, New Delhi. Google Scholar öffnen DOI: 10.5771/9783845262321
  306. Doloreux, David & Saeed Parto (2005), Regional innovation systems: Current discourse and unresolved issues, Technology in Society, 27(2), 133-153. Google Scholar öffnen DOI: 10.5771/9783845262321
  307. Dos Santos, L. & I. Heineck (2012), Drug utilization study in pediatric prescriptions of a university hospital in southern brazil: off-label, unlicensed and high-alert medications, Farmacia Hospitalaria, 36(4), 180-186. Google Scholar öffnen DOI: 10.5771/9783845262321
  308. Dosi, Giovanni (1988), The nature of the innovative process, in: Giovanni Dosi et al. (Hrsg.), Technical Change and Economic Theory, London: Pinter, 221-238. Google Scholar öffnen DOI: 10.5771/9783845262321
  309. Dosi, Giovanni & Luc Soete (1988), Technological change and international trade, in: Giovanni Dosi et al. (Hrsg.), Technical Change and Economic Theory, London: Pinter, 401-431. Google Scholar öffnen DOI: 10.5771/9783845262321
  310. Dr. Reddy's (2002), Annual Report 2001-2002, Hyderabad, <http://www.drreddys.com/investors/pdf/annualreport2002.pdf>. Google Scholar öffnen DOI: 10.5771/9783845262321
  311. Drahos, Peter & John Braithwaite (2002), Information Feudalism, London: Earthscan Publications. Google Scholar öffnen DOI: 10.5771/9783845262321
  312. Draude, Anke (2007), How to Capture Non-Western Forms of Governance: In Favour of an Equivalence Functionalist Observation of Governance in Areas of Limited Statehood, SFB-Governance Working Paper Series, Berlin: Research Center (SFB) 700. Google Scholar öffnen DOI: 10.5771/9783845262321
  313. Dreyfuss, Rochelle (2009), The Role of India, China, Brazil and Other Emerging Economies in Establishing Access Norms for Intellectual Property and Intellectual Property Lawmaking, International Law and Justice Working Papers, No. 5, New York: Institute for International Law and Justice, New York University School of Law. Google Scholar öffnen DOI: 10.5771/9783845262321
  314. DSF (oJ), Selling Out To MNCs: R&D Deal Between Glaxo And Ranbaxy By Amit Sen Gupta, Delhi Science Forum, <http://www.delhiscienceforum.net/ Google Scholar öffnen DOI: 10.5771/9783845262321
  315. pharmaceuticals/245-selling-out-to-mncs-rad-deal-between-glaxo-and-ranba Google Scholar öffnen DOI: 10.5771/9783845262321
  316. xy-by-amit-sen-gupta-.html>. Google Scholar öffnen DOI: 10.5771/9783845262321
  317. DTOLA (2011a), Flawed agreement – BMS Matrix agreement on AIDS drug, 29.06.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  318. DTOLA (2011b), Will India go for Compulsory Licensing for providing improved access to life saving medicines?, 11.04.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  319. DTOLA (2012), BMS sues Mylan (Matrix) Labs for selling generic version of HIV drug Atazanavir to PAHO, 03.08.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  320. Eaton, Jonathan & Samuel Kortum (1995), Engines of Growth: Domestic and Foreign Sources of Innovation, NBER Working Paper Series, No. 5207, Cambridge: National Bureau of Economic Research,. Google Scholar öffnen DOI: 10.5771/9783845262321
  321. Ecks, Stefan (2008), Global pharmaceutical markets and corporate citizenship: the case of Novartis' anti-cancer drug Glivec, BioSocieties, 3, 165-181. Google Scholar öffnen DOI: 10.5771/9783845262321
  322. Economic Times (2002), Ranbaxy ends two pacts with Eli Lilly, 01.02.02. Google Scholar öffnen DOI: 10.5771/9783845262321
  323. Economic Times (2003), Matrix reloaded with more products, 28.07.03. Google Scholar öffnen DOI: 10.5771/9783845262321
  324. Economic Times (2005), Will Vision Garuda help Ranbaxy become a high flyer?, 15.10.05. Google Scholar öffnen DOI: 10.5771/9783845262321
  325. Economic Times (2006a), AIDS drug Viread prices may dip soon, 04.09.06. Google Scholar öffnen DOI: 10.5771/9783845262321
  326. Economic Times (2006b), US pharma major Mylan buys Matrix Labs, 29.08.06. Google Scholar öffnen DOI: 10.5771/9783845262321
  327. Economic Times (2006c), Wockhardt signs in-licensing agreement with UK, 05.06.06. Google Scholar öffnen DOI: 10.5771/9783845262321
  328. Economic Times (2011a), Failures and doubting investors have not dissuaded Glenmark Pharma's Glenn Saldanha, 22.05.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  329. Economic Times (2011b), Lupin signs strategic deal with Brazilian firm Farmanguinhos, 05.01.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  330. Economic Times (2011c), Natco Pharma files India's first compulsory licence plea, 02.08.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  331. Economic Times (2011d), No additional norms to issue compulsory drug licences, 12.04.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  332. Economic Times (2012), Emcure signs deal to manufacture Roche's anti-cancer drugs, 02.03.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  333. Economic Times (2013a), Compulsory licence likely for three cancer drugs, 14.01.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  334. Economic Times (2013b), Swiss drug major Roche to drop anti-cancer drug Herceptin patent in India, 16.08.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  335. Edquist, Charles (Hrsg.) (1997), Systems of Innovation: Technologies, Institutions and Organisations, London: Pinter. Google Scholar öffnen DOI: 10.5771/9783845262321
  336. Edquist, Charles (2001a), The Systems of Innovation Approach and Innovation Policy: An account of the state of the art, Lead paper presented at the DRUID Conference, Aalborg, 12.-15. Juni. Google Scholar öffnen DOI: 10.5771/9783845262321
  337. Edquist, Charles (2001b), Systems of Innovation for Development (SID), Background Paper for Chapter I: «Competitiveness, Innovation and Learning: Analytical Framework” for the UNIDO World Industrial Development Report (WIDR), 2001, Linköping: Department of Technology and Social Change, Linköping University, 31.01.01. Google Scholar öffnen DOI: 10.5771/9783845262321
  338. Edquist, Charles (2005), Systems of Innovation: Perspectives and Challenges, in: Jan Fagerberg et al. (Hrsg.), Oxford Handbook of Innovation, Oxford: Oxford University Press, 181-208. Google Scholar öffnen DOI: 10.5771/9783845262321
  339. Edquist, Charles & Leif Hommen (2006), Comparing National Systems of Innovation in Asia and Europe: Growth, Globalisation, Change and Policy, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen DOI: 10.5771/9783845262321
  340. Edquist, Charles & Bengt-Åke Lundvall (1993), Comparing the Danish and Swedish Systems of Innovation, in: Richard R. Nelson (Hrsg.), National Innovation Systems: A Comparative Analysis, Oxford: Oxford University Press, 265-297. Google Scholar öffnen DOI: 10.5771/9783845262321
  341. Eimer, Thomas R. & Susanne Lütz (2010), Developmental States, Civil Society and Public Health: Patent Regulation for HIV/AIDS Vaccines in India and Brazil, Regulation and Governance, 4(2), 135-153. Google Scholar öffnen DOI: 10.5771/9783845262321
  342. Eimer, Thomas R., Susanne Lütz & Verena Schüren (2013), Norm diffusion through Advocacy Coalitions: Implementing international intellectual property norms in India and Brazil, ISA 54th Annual Convention, San Francisco, 03.-07. April. Google Scholar öffnen DOI: 10.5771/9783845262321
  343. Eimer, Thomas R. & Verena Schüren (2013), Convenient Stalemates: Why International Patent Law Negotiations continue despite Deadlock, New Political Economy, 18(4), 533-554. Google Scholar öffnen DOI: 10.5771/9783845262321
  344. Eren-Vural, Ipek (2007), Domestic contours of global regulation, Understanding the policy changes on pharmaceutical patents in India and Turkey, Review of International Political Economy, 14(1), 105-142. Google Scholar öffnen DOI: 10.5771/9783845262321
  345. Ernst & Young Terco (2011), Doing business in Brazil, <http://www.ey.com/ Google Scholar öffnen DOI: 10.5771/9783845262321
  346. Publication/vwLUAssets/Doing_business_in_Brazil_2011/$FILE/Doing% Google Scholar öffnen DOI: 10.5771/9783845262321
  347. 20Business%20in%20Brazil%202011.pdf>. Google Scholar öffnen DOI: 10.5771/9783845262321
  348. Ernst, Dieter (1994), What are the Limits to the Korean Model? The Korean Electronics Industry Under Pressure, BRIE research paper, Berkeley: University of California,. Google Scholar öffnen DOI: 10.5771/9783845262321
  349. Ernst, Dieter (2002), Global production networks and the changing geography of innovation systems: Implications for developing countries, Economics of Innovation and New Technology, 11(6), 497-523. Google Scholar öffnen DOI: 10.5771/9783845262321
  350. Ernst, Dieter, Tom Ganiatsos & Lynn Mytelka (Hrsg.) (1998), Technological Capabilities and Export Success in East Asia, London: Routledge. Google Scholar öffnen DOI: 10.5771/9783845262321
  351. Eßer, Klaus et al. (2001), Systemische Wettbewerbsfähigkeit und Entwicklung, in: Reinold E. Thiel (Hrsg.), Neue Ansätze zur Entwicklungstheorie, Bonn: DSE/IZEP, 147-163. Google Scholar öffnen DOI: 10.5771/9783845262321
  352. Estadão.com.br (2011), Governo faz acordo para produzir novos medicamentos, <http://www.estadao.com.br/noticias/impresso,governo-faz-acordo-para-produ Google Scholar öffnen DOI: 10.5771/9783845262321
  353. zir-novos-medicamentos,702296,0.htm>. Google Scholar öffnen DOI: 10.5771/9783845262321
  354. Evans, Peter (1995), Embedded Autonomy: States and Industrial Transformation, Princeton: Princeton University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  355. EXIM Bank of India (2007), Indian Pharmaceutical Industry: Surging Globally, Occasional Paper, No. 119, Mumbai: Export-Import Bank of India,. Google Scholar öffnen DOI: 10.5771/9783845262321
  356. Expressindia (2000), Wockhardt, German partner unveil vaccine for hepatitis-B, 13.03.00. Google Scholar öffnen DOI: 10.5771/9783845262321
  357. Expressindia (2001), Allergan, Nicholas Piramal to strengthen JV, 28.03.01. Google Scholar öffnen DOI: 10.5771/9783845262321
  358. Fagerberg, Jan (1996), Technology and competitiveness, Oxford Review of Economic Policy, 12(3), 39-51. Google Scholar öffnen DOI: 10.5771/9783845262321
  359. Fagerberg, Jan & Martin Srholec (2008), National innovation systems, capabilities and economic development, Research Policy, 37(9), 1417-1435. Google Scholar öffnen DOI: 10.5771/9783845262321
  360. Feinson, Stephen (2003), National Innovation Systems Overview and Country Cases, in: CSPO et al. (Hrsg.), Knowledge Flows and Knowledge Collectives: Understanding The Role of Science and Technology Policies in Development, Volume 1: Knowledge Flows, Innovation, and Learning in Developing Countries, New York: Global Inclusion Program of the Rockefeller Foundation, 13-38. Google Scholar öffnen DOI: 10.5771/9783845262321
  361. Ferrer, Marcela et al. (2004), The scientific muscle of Brazil’s health biotechnology, Nature Biotechnology, 22(12s), DC8 - DC12. Google Scholar öffnen DOI: 10.5771/9783845262321
  362. Ferro do Lago, Regina & Nilson do Rosário Costa (2009), Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program, Cadernos de Saúde Pública, 25(10), 2273-2284. Google Scholar öffnen DOI: 10.5771/9783845262321
  363. FierceBiotech (2008), Wockhardt takes huge strides towards In-licensing and collaborative agreements, 10.10.08. Google Scholar öffnen DOI: 10.5771/9783845262321
  364. Filho, Jorge Elisa Kalil (2011), Panorama regulatório da pesquisa no Brasil, in: Ricardo Ubiraci Sennes & Antonio Britto Filho (Hrsg.), Inovações tecnológicas no Brasil, São Paulo: Cultura Acadêmica, 233-266. Google Scholar öffnen DOI: 10.5771/9783845262321
  365. Filho, Pedro Lins Palmeira & Luciana Xavier de Lemos Capanema (2010), A Cadeia Farmacêutica Nacional E O Desafio Da Inovação: Possibilidades Para A Atuação Do Bndes E Outros Agentes, XXX Encontro Nacional De Engenharia De Produção, São Carlos, 07. September. Google Scholar öffnen DOI: 10.5771/9783845262321
  366. Finanznachrichten (2006), Dr. Reddy's, ClinTec pen cancer drug pact, 27.09.06. Google Scholar öffnen DOI: 10.5771/9783845262321
  367. Fiocruz (2011), Medicamento para pacientes transplantados, Google Scholar öffnen DOI: 10.5771/9783845262321
  368. <http://www2.far.fiocruz.br/farmanguinhos/index.php?option=com_content&view=article&id=298:farmanguinhos-vai-produzir-medicamento-para-pacien Google Scholar öffnen DOI: 10.5771/9783845262321
  369. tes-transplantados&catid=53:outras-noticias&Itemid=94>. Google Scholar öffnen DOI: 10.5771/9783845262321
  370. Firstpost (2012), Cipla’s brave act: Will cancer treatment go the AIDS way?, 12.11.12, <http://www.firstpost.com/business/ciplas-brave-act-will-cancer-treat Google Scholar öffnen DOI: 10.5771/9783845262321
  371. ment-go-the-aids-way-523057.html>. Google Scholar öffnen DOI: 10.5771/9783845262321
  372. Floricel, Serghei, John Michela & Mark George (2009), Resource Feedbacks for Continuous Innovation: The Articulation of Firm, University, and Government Roles, Summer Conference 2009 on Copenhagen Business School, Frederiksberg, 17.-19. Juni. Google Scholar öffnen DOI: 10.5771/9783845262321
  373. Flynn, Matthew (2008), Public Production of Anti-Retroviral Medicines in Brazil, 1990-2007, Development and Change, 39(4), 513-536. Google Scholar öffnen DOI: 10.5771/9783845262321
  374. Focus Reports (2012), Brazil: Pharma Report, <http://issuu.com/focusreports/docs/ Google Scholar öffnen DOI: 10.5771/9783845262321
  375. phex_brazil_2012>. Google Scholar öffnen DOI: 10.5771/9783845262321
  376. Folha de S.Paulo (2012), Novartis e Furp fecham acordo de transferência, 09.11.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  377. Fransman, Martin (1984), Technological Capability in the Third World: An Overview and Introduction to some of the Issues raised in this Book, in: Martin Fransman & Kenneth King (Hrsg.), Technological Capability in the Third World, London: Macmillan, 3-30. Google Scholar öffnen DOI: 10.5771/9783845262321
  378. Freeman, Chris (1995), The 'National System of Innovation' in historical perspective, Cambridge Journal of Economics, 19(1), 5-24. Google Scholar öffnen DOI: 10.5771/9783845262321
  379. Freeman, Christopher (1982), The Economics of Industrial Innovation, Cambridge: MIT Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  380. Freeman, Christopher (1987), Technology Policy and Economic Performance: Lessons from Japan, London: Pinter. Google Scholar öffnen DOI: 10.5771/9783845262321
  381. Freeman, Christopher (1988), Japan: a new national system of innovation?, in: Giovanni Dosi et al. (Hrsg.), Technical Change and Economic Theory, London: Pinter, 330-348. Google Scholar öffnen DOI: 10.5771/9783845262321
  382. Frew, Sarah E. et al. (2007), India's health biotech sector at a crossroads, Nature Biotechnology, 25(4), 403-528. Google Scholar öffnen DOI: 10.5771/9783845262321
  383. Fritz, Barbara (1999), Implikationen der Asienkrise für das lateinamerikanische Entwicklungsmodell der 90er Jahre, Lateinamerika. Analysen-Daten-Dokumen¬tationen, 16(40), 17-31. Google Scholar öffnen DOI: 10.5771/9783845262321
  384. Fromhold-Eisebith, Martina (2006), Effectively linking international, national, and regional innovation systems: insights from India and Indonesia, in: Bengt-Åke Lundvall et al. (Hrsg.), Asia’s Innovation Systems in Transition, Cheltenham: Edward Elgar, 75-99. Google Scholar öffnen DOI: 10.5771/9783845262321
  385. Fu, Xiaolan, Carlo Pietrobelli & Luc Soete (2011), The Role of Foreign Technology and Indigenous Innovation in the Emerging Economies: Technological Change and Catching Up, World Development, 39(7), 1204-1212. Google Scholar öffnen DOI: 10.5771/9783845262321
  386. Furtado, Celso (1970), Economic Development of Latin America: A Survey from Colonial Times to the Cuban Revolution, Oxford: Oxford University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  387. Gadelha, Carlos (2011), A Perspectiva do Complexo Industrial da Saúde: o desenvolvimento industrial e científico do setor e rumos para a assistência farmacêutica, Seminário Valor Econômico Perspectivas do Setor Saúde no Brasil, São Paulo: Valor Econômico S.A., 16. März. Google Scholar öffnen DOI: 10.5771/9783845262321
  388. Galli, Riccardo & Morris Teubal (1997), Paradigmatic Shifts in National Innovation Systems, in: Charles Edquist (Hrsg.), Systems of Innovation: Technologies, Institutions and Organisations, London: Pinter, 342-370. Google Scholar öffnen DOI: 10.5771/9783845262321
  389. George, Alexander L. & Andrew Bennett (2005), Case Studies and Theory Development in the Social Sciences, Cambridge: MIT Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  390. George, Julie, Ramaya Sheshadri & Anand Grover (2009), Intellectual Property and Access to Medicines: Developments and Civil Society Initiatives in India, in: Renata Reis et al. (Hrsg.), Intellectual Property Rights and Access to ARV Medicines: Civil Society Resistance in the Global South, Rio de Janeiro: Brazilian Interdisciplinary AIDS Association, 110-136. Google Scholar öffnen DOI: 10.5771/9783845262321
  391. Gereffi, Gary (1999), International Trade and Industrial Upgrading in the Apparel Commodity Chain, Journal of International Economics, 48(1), 37-70. Google Scholar öffnen DOI: 10.5771/9783845262321
  392. Gereffi, Gary (2014), Global value chains in a post-Washington Consensus world, Review of International Political Economy, 21(1), 9-37. Google Scholar öffnen DOI: 10.5771/9783845262321
  393. Gereffi, Gary, John Humphrey & Timothy Sturgeon (2005), The governance of global value chains, Review of International Political Economy, 12(1), 78-104. Google Scholar öffnen DOI: 10.5771/9783845262321
  394. Gerring, John (2004), What Is a Case Study and What Is It Good for?, American Political Science Review, 98(2), 341-354. Google Scholar öffnen DOI: 10.5771/9783845262321
  395. Gerring, John (2007), Case Study Research: Principles and Practices, Cambridge: Cambridge University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  396. Gilead Sciences (2011), Gilead Expands Access Program for Medications in Developing World, 12.07.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  397. Gilead Sciences (2013), Scaling Up Antiretroviral Treatment Sustainably: Gilead Sciences Programs in Developing Countries, November 2013. Google Scholar öffnen DOI: 10.5771/9783845262321
  398. GIPI (2012), Relatório de Análise e Sugestão de Critérios, Mecanismos, Procedimentos, Obrigações e Possíveis Instrumentos Formais para Articulação Entre a Anvisa e o Inpi com Vistas à Execução do Art. 229-C da Lei No. 9.279/1996, Brasília: Grupo Interministerial de Propriedade Intelectual, 19. Januar. Google Scholar öffnen DOI: 10.5771/9783845262321
  399. Girtler, Roland (2001), Methoden der Feldforschung, Wien: Böhlau. Google Scholar öffnen DOI: 10.5771/9783845262321
  400. Girvan, Norman P. (1987), Transnational corporations and non-fuel primary commodities in developing countries, World Development, 15(5), 713-740. Google Scholar öffnen DOI: 10.5771/9783845262321
  401. Giugale, Marcelo (2011), Yes, They Can: How Emerging Economies Are Building Universal Health Coverage, Huffington Post, 05.07.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  402. Giuliani, Elisa, Carlo Pietrobelli & Roberta Rabellotti (2005), Upgrading in Global Value Chains: Lessons from Latin American Clusters, World Development, 33(4), 549-573. Google Scholar öffnen DOI: 10.5771/9783845262321
  403. Gläser, Jochen & Grit Laudel (2004), Experteninterviews und qualitative Inhaltsanalyse, Wiesbaden: VS Verlag für Sozialwissenschaften. Google Scholar öffnen DOI: 10.5771/9783845262321
  404. globo.com (2008), INPI nega patente ao anti-retroviral Tenofovir, 02.09.08. Google Scholar öffnen DOI: 10.5771/9783845262321
  405.   Google Scholar öffnen DOI: 10.5771/9783845262321
  406. Gontijo, Cicero (2005), Die Veränderungen im Patentsystem: Von der Pariser Verbandsübereinkunft zum TRIPS-Abkommen. Die Position Brasiliens, in: Thomas Fritz et al. (Hrsg.), Produktion der Abhängigkeit: Wertschöpfungsketten. Investitionen. Patente, Berlin: Forschungs- und Dokumentationszentrum Chile - Lateinamerika e.V., 79-100. Google Scholar öffnen DOI: 10.5771/9783845262321
  407. Gopakumar, K.M. (2010), India: A Critical Review of the Implementation of TRIPS Patent Regime, The Law and Development Review, 3(2), 324-368. Google Scholar öffnen DOI: 10.5771/9783845262321
  408. Gouveia, Roberto (2005), Parliamentary Bill 22/03, Brazil, National Congress. Google Scholar öffnen DOI: 10.5771/9783845262321
  409. Gräbe, Hans-Gert (2005), Die Macht des Wissens in der modernen Gesellschaft, Utopie kreativ,(177/178), 629-643. Google Scholar öffnen DOI: 10.5771/9783845262321
  410. Granstrand, Ove (2005), Innovation and Intellectual Property Rights, in: Jan Fagerberg et al. (Hrsg.), The Oxford Handbook of Innovation, Oxford: Oxford University Press, 266-290. Google Scholar öffnen DOI: 10.5771/9783845262321
  411. Granstrand, Ove (2011), The economics of IP in the context of a shifting innovation paradigm, Contribution to the WIPO Innovation Report 2011 «Shifting Innovation Paradigms and the Role of Intellectual Property”, May. Google Scholar öffnen DOI: 10.5771/9783845262321
  412. Greenhalgh, Christine & Mark Rogers (2010), Innovation, Intellectual Property, and Economic Growth, Princeton: Princeton University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  413. Grosse Ruse-Khan, Henning (2009), Policy Space for Domestic Public Interest Measures Under TRIPS, South Centre Research Papers, No. 22, Geneva: The South Centre, Juli 2009. Google Scholar öffnen DOI: 10.5771/9783845262321
  414. Grover, Anand (2013), Analysing the Supreme Court Judgment, Economic & Political Weekly, 44(32), 46-49. Google Scholar öffnen DOI: 10.5771/9783845262321
  415. Gualini, Enrico (2006), Mehrebenen-Governance und neue Formen von Territorialität, in: Ralf Kleinfeld et al. (Hrsg.), Regional Governance: Steuerung, Koordination und Kommunikation in regionalen Netzwerken als neue Formen des Regierens, Düsseldorf: V&R Unipress, 61-82. Google Scholar öffnen DOI: 10.5771/9783845262321
  416. Guellec, Dominique (2007), Patents as an Incentive to Innovate, in: Dominique Guellec & Bruno van Pottelsberghe de la Potterie (Hrsg.), The Economics of the European Patent System: IP Policy for Innovation and Competition, Oxford: Oxford University Press, 46-84. Google Scholar öffnen DOI: 10.5771/9783845262321
  417. Guennif, Samira & Shyama V. Ramani (2010), Catching up in pharmaceuticals: a comparative study of India and Brazil, UNU-MERIT Working Papers, No. 19, Maastricht: United Nations University. Google Scholar öffnen DOI: 10.5771/9783845262321
  418. Guennif, Samira & Shyama V. Ramani (2012), Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework, Research Policy, 41(2), 430-441. Google Scholar öffnen DOI: 10.5771/9783845262321
  419. Guise Rosina, Monica Steffen, Daniel Wei Liang Wang & Thana Cristina de Campos (2010), Access to Medicines: Pharmaceutical Patents and the Right to Health in: Lea Shaver (Hrsg.), Access to Knowledge in Brazil: New Research on Intellectual Property, Innovation and Development, London: Bloomsbury, 103-134. Google Scholar öffnen DOI: 10.5771/9783845262321
  420. Hall, Peter A. (2003), Aligning Ontology and Methodology in Comparative Research, in: James Mahoney & Dietrich Rueschemeyer (Hrsg.), Comparative Historical Analysis in the Social Sciences, Cambridge: Cambridge University Press, 373-404. Google Scholar öffnen DOI: 10.5771/9783845262321
  421. Hall, Peter A. & Kathleen Thelen (2009), Institutional change in varieties of capitalism, Socio-Economic Review, 7(1), 7-34. Google Scholar öffnen DOI: 10.5771/9783845262321
  422. Hartmann, Jürgen (1995), Vergleichende Politikwissenschaft: Ein Lehrbuch, Frankfurt: Campus. Google Scholar öffnen DOI: 10.5771/9783845262321
  423. Hasenclever, Lia & Julia Paranhos (2009), The development of the pharmaceutical industry in Brazil and India: technological capability and industrial development, Rio de Janeiro: Federal University, Economics Institute. Google Scholar öffnen DOI: 10.5771/9783845262321
  424. Hassan, Emmanuel, Ohid Yaqub & Stephanie Diepeveen (2010), Intellectual Property and Developing Countries: A review of the literature, Technical Reports, TR-804-IPO, Santa Monica: RAND Corporation. Google Scholar öffnen DOI: 10.5771/9783845262321
  425. Hausmann, Ricardo & Bailey Klinger (2007), The Structure of the Product Space and the Evolution of Comparative Advantage, CID Working Paper, No. 146, Cambridge: Center for International Development at Harvard University. Google Scholar öffnen DOI: 10.5771/9783845262321
  426. Hein, Wolfgang (1998), Unterentwicklung – Krise der Peripherie: Phänomene, Theorien, Strategien, Opladen: Leske + Budrich. Google Scholar öffnen DOI: 10.5771/9783845262321
  427. Hemmer, Hans-Rimbert & Rainer Wilhelm (2001), Neue Hoffnung für Entwicklungsländer? Entwicklungspolitische Implikationen endogener Wachstumstheorien, in: Reinold E. Thiel (Hrsg.), Neue Ansätze zur Entwicklungstheorie, Bonn: Deutsche Stiftung für internationale Entwicklung, 249-258. Google Scholar öffnen DOI: 10.5771/9783845262321
  428. Herring, Ronald J. (1999), Embedded Particularism: India's Failed Devleopmental State, in: Meredith Woo-Cumings (Hrsg.), The Developmental State, Ithaca: Cornell University Press, 306-332. Google Scholar öffnen DOI: 10.5771/9783845262321
  429. Herrmann, Margaret G. (2008), Content Analysis, in: Audie Klotz & Deepa Prakash (Hrsg.), Qualitative Methods in International Relations: A Pluralist Guide, Basingstoke: Palgrave Macmillan, 151-167. Google Scholar öffnen DOI: 10.5771/9783845262321
  430. Hirschman, Albert O. (1958), The Strategy of Economic Development, New Haven: Yale University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  431. Hobday, Michael (1995), Innovation in East Asia: The Challenge to Japan, Aldershot: Edward Elgar. Google Scholar öffnen DOI: 10.5771/9783845262321
  432. Hoffmann, Jean (2005), Generics Growth in the USA and the EU: The Role of India, Journal of Generic Medicines, 3(1), 7-19. Google Scholar öffnen DOI: 10.5771/9783845262321
  433. Hollingsworth, J. Rogers & Robert Boyer (Hrsg.) (1997), Contemporary Capitalism: The Embeddedness of Institutions, Cambridge: Cambridge University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  434. Hooda, Shailender Kumar (2013), Changing Pattern of Public Expenditure on Health in India: Issues and Challenges, Working Paper Series, No. 01, New Delhi: ISID-PHFI Collaborative Research Centre Institute for Studies in Industrial Development. Google Scholar öffnen DOI: 10.5771/9783845262321
  435. Horner, Rory (2013), The Impact of Patents on Innovation, Technology Transfer and Health: A Pre- and Post-TRIPs Analysis of India's Pharmaceutical Industry, New Political Economy, DOI:10.1080/13563467.2013.796446. Google Scholar öffnen DOI: 10.5771/9783845262321
  436. Howells, Jeremy (1999), Regional systems of innovation?, in: Daniele Archibugi et al. (Hrsg.), Innovation Policy in a Global Economy, Cambridge: Cambridge University Press, 67-93. Google Scholar öffnen DOI: 10.5771/9783845262321
  437. HP (2012), CSIR and HP announce the launch of a rapidly deployable and fully integrated cloud-enabled eHealth Centre, 11.12.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  438. Hubaceka, Klaus, Dabo Guana & Anamika Baruaa (2007), Changing lifestyles and consumption patterns in developing countries: A scenario analysis for China and India, Futures, 39(9), 1084-1096. Google Scholar öffnen DOI: 10.5771/9783845262321
  439. Huibo, Zhong & Zheng Bingwen (2011), Comparison of Government Functions of BRIC in «National Innovation System”: From the Degree of Homoplasy and Embeddedness, in: Li Yang (Hrsg.), BRICs & the global transformation: Considerations on the BRIC Summit of Think Tanks in Brasilia, Reading: Social Sciences Academic Press, 139-165. Google Scholar öffnen DOI: 10.5771/9783845262321
  440. Humphrey, John & Hubert Schmitz (2000), Governance and Upgrading: Linking Industrial Cluster and Global Value Chain Research, Institute of Development Studies, IDS Working Paper 120, Brighton: University of Sussex,. Google Scholar öffnen DOI: 10.5771/9783845262321
  441. Humphrey, John & Hubert Schmitz (2002), How does insertion in global value chains affect upgrading in industrial clusters?, Regional Studies, 36(9), 1017-1027. Google Scholar öffnen DOI: 10.5771/9783845262321
  442. IBGE (2010), Pesquisa de Inovação Tecnológica, Instituto Brasileiro de Geografia e Estatística, Ministério do Planejamento, Orçamento e Gestão, Rio de Janeiro. Google Scholar öffnen DOI: 10.5771/9783845262321
  443. ICIS news (2003), Matrix rejects Lundbeck's DKr300m offer to halt production, 14.02.03. Google Scholar öffnen DOI: 10.5771/9783845262321
  444. ICRA (2011), CRAMS India: Overview & Outlook, Juni 2011, <http://www.icra.in/ Google Scholar öffnen DOI: 10.5771/9783845262321
  445. Files/Articles/CRAMS%20Note,%20Overview%20and%20Outlook.pdf>. Google Scholar öffnen DOI: 10.5771/9783845262321
  446. IMF (2003), World Economic Outlook April 2003: Growth and Institutions, Washington, D.C.: International Monetary Fund. Google Scholar öffnen DOI: 10.5771/9783845262321
  447. India Daily (2007), A new trend in emerging nations - Brazil opts for Indian generic drug ignoring US pharmaceutical giant Merck’s patent on AIDS drug Efavirenz, 06.05.07. Google Scholar öffnen DOI: 10.5771/9783845262321
  448. IP Health (2006), Brazil consideration of compulsory license of Viread patents, 22.12.06. Google Scholar öffnen DOI: 10.5771/9783845262321
  449. IP Health (2012), Ip-health Digest, Ip-health Digest, 29(16). Google Scholar öffnen DOI: 10.5771/9783845262321
  450. IP Tango (2009), Brazilian PPPs in the Pharma Industry, 06.04.09. Google Scholar öffnen DOI: 10.5771/9783845262321
  451. IP Tango (2011), Brazil and the antidepressant market: changing the mood, 23.08.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  452. IP Watch (2008), US, Indian HIV/AIDS Drug Rulings Could Reverberate In Brazil, 04.07.08. Google Scholar öffnen DOI: 10.5771/9783845262321
  453. IP Watch (2010), Inside Views: Big Pharma Stranglehold: Thwarting India As Independent Maker Of Blockbuster HIV Drugs?, 28.10.10. Google Scholar öffnen DOI: 10.5771/9783845262321
  454. IP Watch (2012), India Grants First Compulsory Licence, For Bayer Cancer Drug, 12.03.2012. Google Scholar öffnen DOI: 10.5771/9783845262321
  455. IP Watch (2013), Inside Views: The Novartis Decision: A Tale Of Developing Countries, IP, And The Role Of The Judiciary, 15.04.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  456. IPR (2010), Indian President Patil speaks at Inauguration of National Seminar on Recent Trends in Pharmacy Education and Practice, New Delhi: The Office of President of India, 09.07.10. Google Scholar öffnen DOI: 10.5771/9783845262321
  457. Jaffe, Adam B. & Josh Lerner (2004), Innovation and Its Discontents: How Our Broken Patent System is Endangering Innovation and Progress, and What to Do About It, Princeton: Princeton University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  458. Jahn, Detlef (2005), Fälle, Fallstricke und die komparative Methode in der vergleichenden Politikwissenschaft, in: Sabine Kropp & Michael Minkenberg (Hrsg.), Vergleichen in der Politikwissenschaft, Wiesbaden: VS Verlag für Sozialwissenschaften, 55-75. Google Scholar öffnen DOI: 10.5771/9783845262321
  459. Jeffrey, Roger & MR Santhosh (2009), Architecture of Drug Regulation in India. What are the Barriers to Regulatory Reform?, Journal of Health Studies, 2(1-3), 13-31. Google Scholar öffnen DOI: 10.5771/9783845262321
  460. Johnson, Björn, Charles Edquist & Bengt-Åke Lundvall (2003), Economic Development and the National System of Innovation Approach, 1st GLOBELICS Conference: Innovation Systems and Development Strategies for the Third Millennium, Rio de Janeiro, 03.-06. November. Google Scholar öffnen DOI: 10.5771/9783845262321
  461. Johnson, Björn & Bengt-Åke Lundvall (2003), Promoting innovation systems as a response to the globalizing learning economy, in: José E. Cassiolato et al. (Hrsg.), Systems of Innovation: Evidence from Brazil, Cheltenham: Edward Elgar, 141-184. Google Scholar öffnen DOI: 10.5771/9783845262321
  462. Joyce, Joseph P. & Ilan Noy (2005), The IMF and the Liberalization of Capital Flows, East-West Center Working Papers, Economics Series, Honolulu: East-West Center,. Google Scholar öffnen DOI: 10.5771/9783845262321
  463. Juma, Calestous et al. (2001), Global governance of technology: meeting the needs of developing countries, International Journal of Technology Management, 22(7/8), 629-655. Google Scholar öffnen DOI: 10.5771/9783845262321
  464. Kaiser Health News (2005), Brazil Requests Voluntary Licensing for AIDS Drugs To Treat More Patients, Reduce Costs of Importing Patented Drugs, 16.03.05. Google Scholar öffnen DOI: 10.5771/9783845262321
  465. Kale, Dinar & Steve Little (2007), From Imitation to Innovation: The Evolution of R&D Capabilities and Learning Processes in the Indian Pharmaceutical Industry, Technology Analysis & Strategic Management, 19(5), 589-609. Google Scholar öffnen DOI: 10.5771/9783845262321
  466. Kapczynski, Amy (2009), Harmonization and Its Discontents: A case Study of TRIPS Implementation in India's Pharmaceutical Sector, California Law Review, 97, 1571-1650. Google Scholar öffnen DOI: 10.5771/9783845262321
  467. Kapczynski, Amy (2013), Engineered in India — Patent Law 2.0, The New England Journal of Medicine, 369(6), 497-499. Google Scholar öffnen DOI: 10.5771/9783845262321
  468. Kaplinsky, Raphael (2000), Globalisation and Unequalisation: What Can Be Learned from Value Chain Analysis?, Journal of Development Studies, 37(2), 117-146. Google Scholar öffnen DOI: 10.5771/9783845262321
  469. KEI (2012), KEI Statement on India's granting of compulsory license to patents on cancer drug sorafenib (NATCO Vs. BAYER), James Love's blog, Knowledge Ecology International, 12.03.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  470. Kessler, Eric H. & Alok K. Chakrabarti (1996), Innovation Speed: A Conceptual Model of Context, Antecedents, and Outcomes, The Academy of Management Review, 21(4), 1143-1191. Google Scholar öffnen DOI: 10.5771/9783845262321
  471. Khader, Feroz Ali (2007), The Law of Patents - With a Special Focus on Pharmaceuticals in India, New Delhi: LexisNexis Butterworths. Google Scholar öffnen DOI: 10.5771/9783845262321
  472. Kim, Linsu (1997), Imitation to Innovation: the Dynamics of Korea’s Technological Learning, Boston: Harvard Business School Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  473. Kim, Linsu (1999), Learning And Innovation In Economic Development, Cheltenham: Edward Elgar. Google Scholar öffnen DOI: 10.5771/9783845262321
  474. King, Gary, Robert O. Keohane & Sidney Verba (1994), Designing Social Inquiry: Scientific Inference in Qualitative Research, Princeton: Princeton University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  475. Kiran, Ravi & Sunita Mishra (2009), Changing Pragmatics of the Indian Pharmaceutical Industry in the Pre and Post TRIPS Period, International Journal of Business and Management, 4(9), 206-220. Google Scholar öffnen DOI: 10.5771/9783845262321
  476. Klein, Helena Espellet, Lia Hasenclever & Carlos José Saldanha Machado (2011), Regulação e Difusão de Tecnologias e sua Influência na Capacitação Tecnológica em Saúde Dos Países em Desenvolvimento, Revista Brasileira de Ciência, Tecnologia e Sociedade, 2(2), 130-149. Google Scholar öffnen DOI: 10.5771/9783845262321
  477. Koeller, Priscila & José Luis Gordon (2013), Brazil, in: Mario Scerri & Helena M. M. Lastres (Hrsg.), The Role of the State, New Delhi: Routledge, 23-79. Google Scholar öffnen DOI: 10.5771/9783845262321
  478. Korzeniewicz, Roberto Patricio (2012), Trends in World Income Inequality and the ‘Emerging Middle, European Journal of Development Research, 24(2), 205-222. Google Scholar öffnen DOI: 10.5771/9783845262321
  479. Krishna, V. V. (2013), India, in: Mario Scerri & Helena M. M. Lastres (Hrsg.), The Role of the State, New Delhi: Routledge, 138-187. Google Scholar öffnen DOI: 10.5771/9783845262321
  480. Krugman, Paul (2009), How Did Economists Get It So Wrong?, The New York Times Sunday Magazine, 06.09.09. Google Scholar öffnen DOI: 10.5771/9783845262321
  481. Kuckartz, Udo (2009), Inhaltsanalyse, in: Bettina Westle (Hrsg.), Methoden der Politikwissenschaft, Baden-Baden: Nomos, 334-344. Google Scholar öffnen DOI: 10.5771/9783845262321
  482. Kuhrt, Nicola (2012), Klinische Studien in Indien: Erst der Test, dann die Moral, Spiegel Online, 09.05.2012. Google Scholar öffnen DOI: 10.5771/9783845262321
  483. Kumar, Nagesh (1998), Technology Generation and Technology Transfer in the World Economy, Science Technology Society, 3, 265-306. Google Scholar öffnen DOI: 10.5771/9783845262321
  484. Kurtz, Marcus J. & Sarah M. Brooks (2008), Embedding Neoliberal Reform in Latin America, World Politics, 2(1), 231-280. Google Scholar öffnen DOI: 10.5771/9783845262321
  485. Lachmann, Werner (2004), Entwicklungspolitik. Band 1: Grundlagen, 1, München: Oldenbourg. Google Scholar öffnen DOI: 10.5771/9783845262321
  486. Laforgia, Francesco, Fabio Montobbio & Luigi Orsenigo (2009), IPRs and Technological Development in Pharmaceuticals. Who is patenting what in Brazil after TRIPS?, in: Neil Weinstock Netanel (Hrsg.), The Development Agenda: Global Intellectual Property and Developing Countries, New York: Oxford University Press, 293-319. Google Scholar öffnen DOI: 10.5771/9783845262321
  487. Lal, Harivansh (1990), Drugs industry, social responsibility, and the multinationals, New Delhi: Commonwealth Publishers. Google Scholar öffnen DOI: 10.5771/9783845262321
  488. Lall, Sanjaya (1992), The Role of Technology in Economic Development, in: Simon Teitel (Hrsg.), Towards a New Development Strategy for Latin America: Pathways from Hirschman's Thought, Washington, D.C.: John Hopkins University Press, 169-218. Google Scholar öffnen DOI: 10.5771/9783845262321
  489. Lall, Sanjaya (1998), Technological capabilities in emerging Asia, Oxford Agrarian Studies, 26(2), 213-243. Google Scholar öffnen DOI: 10.5771/9783845262321
  490. Lall, Sanjaya (1999), India's Manufactured Exports: Comparative Structure and Prospects, World Development, 27(10), 1769-1786. Google Scholar öffnen DOI: 10.5771/9783845262321
  491. Landes, W. & R. Posner (2003), The economic structure of intellectual property law, Cambridge: The Belkup Press of Harvard University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  492. Landesmann, Michael & Robert Stehrer (2004), Global Growth Processes: Technology Diffusion, Catching-up and Effective Demand, wiiw Working Paper, No. 26, Wien: Wiener Institut für Internationale Wirtschaftsvergleiche, Januar. Google Scholar öffnen DOI: 10.5771/9783845262321
  493. Lastres, Helena Maria Martins, José E. Cassiolato & Maria Lucia Maciel (2003), Systems of innovation for development in the knowledge era: an introduction, in: José E. Cassiolato et al. (Hrsg.), Systems of Innovation and Development, Evidence from Brazil, Cheltenham: Edward Elgar, 1-34. Google Scholar öffnen DOI: 10.5771/9783845262321
  494. Lettington, Robert & Mita Manek (1998), "Pandora's Box": TRIPS Article 27 (3) (b) and the CBD, <http://www.iatp.org/files/Pandoras_Box_TRIPs_Article_ Google Scholar öffnen DOI: 10.5771/9783845262321
  495. 273b_and_the_CBD.htm>. Google Scholar öffnen DOI: 10.5771/9783845262321
  496. Levin, Richard C. et al. (1987), Appropriating the Returns from Industrial Research and Development, Brookings Papers on Economic Activity (3: Microeconomics), 783-831. Google Scholar öffnen DOI: 10.5771/9783845262321
  497. Lewis, W. Arthur (1954), Economic Development with Unlimited Supplies of Labour, The Manchester School, 22(2), 139-191. Google Scholar öffnen DOI: 10.5771/9783845262321
  498. Li, Xuan (2008), The Impact of Higher Standards in Patent Protection for Pharmaceutical Industries under the TRIPS Agreement: A Comparative Study of China and India, UNU-WIDER Research Paper, No. 36, Helsinki: UNU World Institute for Development Economics Research,. Google Scholar öffnen DOI: 10.5771/9783845262321
  499. Lijphart, Arend (1971), Comparative politics and the comparative method, American Political Science Review, 65(3), 682-693. Google Scholar öffnen DOI: 10.5771/9783845262321
  500. Lijphart, Arend (1975), The Comparable-Cases Strategy in Comparative Research, Comparative Political Studies, 8(2), 158-177. Google Scholar öffnen DOI: 10.5771/9783845262321
  501. Lind, Hans-Günter & Pedro Gouveia (2012), The Life Sciences Industry in Brazil, Working Paper, Leipzig: Fraunhofer-Zentrum für Mittel- und Osteuropa. Google Scholar öffnen DOI: 10.5771/9783845262321
  502. Lipietz, Alain (1987), Mirages and Miracles: The Crisis of Global Fordism, London: Verso. Google Scholar öffnen DOI: 10.5771/9783845262321
  503. List, Friedrich (1841), Das Nationale System der Politischen Ökonomie, Basel: Kyklos. Google Scholar öffnen DOI: 10.5771/9783845262321
  504. Liu, Xielin & Steven White (2001), Comparing innovation systems: a framework and application to China’s transitional context, Research Policy, 30(7), 1091-1114. Google Scholar öffnen DOI: 10.5771/9783845262321
  505. Livemint (2008), Natco withdraws plea on making patented cancer drugs, 28.09.08. Google Scholar öffnen DOI: 10.5771/9783845262321
  506. Livemint (2009), CSIR lab in second licensing deal with US pharma company, 22.02.09. Google Scholar öffnen DOI: 10.5771/9783845262321
  507. Livemint (2012), Bayer asked to give cost data, 13.01.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  508. Love, James Packard (2007), Recent examples of compulsory licensing of patents, KEI Research Note, No. 2, Washington, D.C.: Knowledge Ecology International. Google Scholar öffnen DOI: 10.5771/9783845262321
  509. Lu, Bingbin (2011), Best Mode Disclosure for Patent Applications: An International and Comparative Perspective, Journal of Intellectual Property Rights, 16(5), 409-417. Google Scholar öffnen DOI: 10.5771/9783845262321
  510. Lundvall, Bengt-Åke (1992), National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning, London: Pinter. Google Scholar öffnen DOI: 10.5771/9783845262321
  511. Lundvall, Bengt-Åke (2007), National Innovation Systems: Analytical Concept and Development Tool, Industry and Innovation, 14(1), 95-119. Google Scholar öffnen DOI: 10.5771/9783845262321
  512. Lundvall, Bengt-Åke, Patarapong Intarakumnerd & Jan Vang (2006), Asia’s Innovation Systems in Transition: An Introduction, in: Bengt-Åke Lundvall et al. (Hrsg.), Asia’s Innovation Systems in Transition, Cheltenham: Edward Elgar, 1-20. Google Scholar öffnen DOI: 10.5771/9783845262321
  513. Lundvall, Bengt-Åke et al. (2002), National systems of production, innovation and competence building, Research Policy, 31, 213-231. Google Scholar öffnen DOI: 10.5771/9783845262321
  514. Lundvall, Bengt-Åke et al. (2009), Innovation System Research and Developing Countries, in: Bengt-Åke Lundvall et al. (Hrsg.), Handbook of Innovation Systems and Developing Countries: Building Domestic Capabilities in a Global Setting, Cheltenham: Edward Elgar, 1-30. Google Scholar öffnen DOI: 10.5771/9783845262321
  515. Lütz, Susanne (2003), Governance in der politischen Ökonomie, MPIfG Discussion Paper, No. 5, Köln: Max-Planck-Institut für Gesellschaftsforschung. Google Scholar öffnen DOI: 10.5771/9783845262321
  516. Mahajan, Madhur Mohit (2011), The Emergence of New R&D Paradigms in the Indian Pharmaceutical Industry: Post TRIPS Period, Journal of Intellectual Property Rights, 16(4), 321-329. Google Scholar öffnen DOI: 10.5771/9783845262321
  517. Mahoney, James (2000), Path dependence in historical sociology, Theory and Society, 29(4), 507-548. Google Scholar öffnen DOI: 10.5771/9783845262321
  518. Malerba, Franco (2005), Sectoral Systems: How and Why Innovation Differs across Sectors, in: Jan Fagerberg et al. (Hrsg.), The Oxford Handbook of Innovation, Oxford: Oxford University Press, 380-406. Google Scholar öffnen DOI: 10.5771/9783845262321
  519. Malerba, Franco (2006), Catch up in different sectoral systems - some introductory remarks, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen DOI: 10.5771/9783845262321
  520. Malerba, Franco & Richard Nelson (2011), Learning and catching up in different sectoral systems: evidence from six industries, Industrial and Corporate Change, 20(6), 1645-1675. Google Scholar öffnen DOI: 10.5771/9783845262321
  521. Mani, Sunil (2006a), The incremental innovator versus the trader contrast between the sectoral system of innovation of the Indian pharmaceutical and telecommunication industries, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen DOI: 10.5771/9783845262321
  522. Mani, Sunil (2006b), The Sectoral System of Innovation of Indian Pharmaceutical Industry, Working Paper, No. 382, Thiruvananthapuram: Centre for Development Studies. Google Scholar öffnen DOI: 10.5771/9783845262321
  523.   Google Scholar öffnen DOI: 10.5771/9783845262321
  524. Manikandan, A.D. (2006), Performance of Foreign Multinationals and Domestic Companies in India since Liberalisation: A Comparative Study, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen DOI: 10.5771/9783845262321
  525. Marcellin, Sherry S. (2010), The Political Economy of Pharmaceutical Patents: US Sectional Interests and the African Group at the WTO, Farnham: Ashgate. Google Scholar öffnen DOI: 10.5771/9783845262321
  526. Maskus, Keith E. (2000), Intellectual Property Rights in the Global Economy, Washington, D.C.: Institute for International Economics. Google Scholar öffnen DOI: 10.5771/9783845262321
  527. May, Christopher (2004), Cosmopolitan legalism meets "thin community": problems in the global governance of intellectual property, Government and Opposition, 39(3), 393-422. Google Scholar öffnen DOI: 10.5771/9783845262321
  528. Mayntz, Renate (2002), Zur Theoriefähigkeit makro-sozialer Analysen, in: Renate Mayntz (Hrsg.), Akteure - Mechanismen - Modelle: Zur Theoriefähigkeit makro-sozialer Analysen, Frankfurt am Main: Campus, 7-43. Google Scholar öffnen DOI: 10.5771/9783845262321
  529. Mayntz, Renate & Fritz W. Scharpf (1995), Der Ansatz des akteurzentrierten Institutionalismus, in: Renate Mayntz & Fritz W. Scharpf (Hrsg.), Gesellschaftliche Selbstregelung und politische Steuerung, Frankfurt am Main: Campus, 39-72. Google Scholar öffnen DOI: 10.5771/9783845262321
  530. Mayntz, Renate et al. (2005), Globale Strukturen und deren Steuerung: Auswertung der Ergebnisse eines Förderprogramms der Volkswagen Stiftung, Forschungsbericht aus dem MPIfG, MPIfG Working Paper No. 5, Köln: Max-Planck-Institut für Gesellschaftsforschung. Google Scholar öffnen DOI: 10.5771/9783845262321
  531. Mazumdar, Mainak (2013), Performance of Pharmaceutical Companies in India: A Critical Analysis of Industrial Structure, Firm Specific Resources, and Emerging Strategies, Heidelberg: Physica Verlag. Google Scholar öffnen DOI: 10.5771/9783845262321
  532. MCTI (2013), Resultado Após Análises dos Recursos, Chamada Pública MCTI / FINEP / Ação Transversal – Inova Empresa – PNI/Parques Tecnológicos 02/2013, Brasília. Google Scholar öffnen DOI: 10.5771/9783845262321
  533. Meckstroth, Theodore W. (1975), «Most Different Systems” and «Most Similar Systems”: A Study in the Logic of Comparative Inquiry, Comparative Political Studies, 8(2), 132-157. Google Scholar öffnen DOI: 10.5771/9783845262321
  534. Menghaney, Leena (2012), India’s patent law on trial, BMJ Group Blogs, 27.09.12. Google Scholar öffnen DOI: 10.5771/9783845262321
  535. Menghaney, Leena (2013), ‘Drop the Case’: Campaigning against Novartis, Economic & Political Weekly, 48(32), 52-54. Google Scholar öffnen DOI: 10.5771/9783845262321
  536. Meuser, Michael & Ulrike Nagel (2009), Experteninterview und der Wandel der Wissensproduktion, in: Alexander Bogner et al. (Hrsg.), Experteninterviews: Theorien, Methoden, Anwendungsfelder, Wiesbaden: VS Verlag für Sozialwissenschaften, 35-60. Google Scholar öffnen DOI: 10.5771/9783845262321
  537. Mill, John Stuart (1884), A system of logic, ratiocinative and inductive: being a connected view of the principles of evidence and the methods of scientific investigation London: Routledge. Google Scholar öffnen DOI: 10.5771/9783845262321
  538. Milstien, Julie B., Patrick Gaulé & Miloud Kaddar (2007), Access to Vaccine Technologies in Developing Countries: Brazil and India, Vaccine, 25(44), 7610-7619. Google Scholar öffnen DOI: 10.5771/9783845262321
  539. Miramontes, Eduardo Zepeda (2006), The Segusino Cluster: Boom and Bust in Furniture Exports, in: Carlo Pietrobelli & Roberta Rabellotti (Hrsg.), Upgrading to Compete: Global Value Chains, Clusters, and SMEs in Latin America, Washington, D.C.: Inter-American Development Bank, 143-174. Google Scholar öffnen DOI: 10.5771/9783845262321
  540. Mkandawire, Thandika (2007), Transformative Social Policy and Innovation in Developing Countries, The European Journal of Development Research, 19(1), 13-29. Google Scholar öffnen DOI: 10.5771/9783845262321
  541. MoCF (2011), National Pharmaceuticals Pricing Policy 2011, Department of Pharmaceuticals, Government of India, Ministry of Chemicals & Fertilizers, New Delhi. Google Scholar öffnen DOI: 10.5771/9783845262321
  542. MoCF (2012), Annual Report 2011-12, Department of Pharmaceuticals, Government of India, Ministry of Chemicals & Fertilizers, New Delhi. Google Scholar öffnen DOI: 10.5771/9783845262321
  543. MoCF (2013), Drug Price Control Order, Department of Pharmaceuticals, Government of India, Ministry of Chemicals & Fertilizers, New Delhi. Google Scholar öffnen DOI: 10.5771/9783845262321
  544. MoCI (2004), Kamal Nath's Statement on the Ordinance Relating to Patents (Third) Amendment, Press Information Bureau, Government of India, Ministry of Commerce & Industry, 27.12.04. Google Scholar öffnen DOI: 10.5771/9783845262321
  545. MoCI (2008), Strategy for Increasing Exports of Pharmaceutical Products: Report of the Task Force, Department of Commerce, Government of India, Ministry of Commerce and Industry, New Delhi. Google Scholar öffnen DOI: 10.5771/9783845262321
  546. Morel, Carlos et al. (2005), Health Innovation Networks to Help Developing Countries Address Neglected Diseases, Science, 309(5733), 401-404. Google Scholar öffnen DOI: 10.5771/9783845262321
  547. Morrison, Andrea (2008), Gatekeepers of Knowledge within Industrial Districts: Who They Are, How They Interact, Regional Studies, 42(6), 817-835. Google Scholar öffnen DOI: 10.5771/9783845262321
  548. Morrison, Andrea, Carlo Pietrobelli & Roberta Rabellotti (2008), Global Value Chains and Technological Capabilities: A Framework to Study Learning and Innovation in Developing Countries, Oxford Development Studies, 36(1), 39-58. Google Scholar öffnen DOI: 10.5771/9783845262321
  549. MoST (2011), Youngsters Should Join Innovative Scientific Research to Secure World Leadership: Deshmukh, Be Globally Competitive to have Cutting Edge Advantage: Ashwani Kumar, Press Information Bureau, Government of India, Ministry of Science & Technology, 26.09.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  550. Mowery, David C. & Joanne E. Oxley (1995), Inward Technology Transfer and Competitiveness: The Role of National Innovation Systems, Cambridge Journal of Economics, 19(1), 67-93. Google Scholar öffnen DOI: 10.5771/9783845262321
  551. Mowery, David & Nathan Rosenberg (1998), Paths of Innovation: Technological Change in 20th-Century America, Cambridge: Cambridge University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  552. MPP (2011), Second Amendment to License Agreement, 14.11.11. Google Scholar öffnen DOI: 10.5771/9783845262321
  553. MPP (2013), Licences in the Pool, Geneva: Medicines Patent Pool. Google Scholar öffnen DOI: 10.5771/9783845262321
  554. MS (2008), Pesquisa em saúde no Brasil, Revista de Saúde Pública, 42(4), 773-775. Google Scholar öffnen DOI: 10.5771/9783845262321
  555. MS (2010), Targets and Commitments made by Member-States at the United Nations General Assembly Special Session on HIV/AIDS, Brazilian Response 2008-2009 Country Progress Report, Brasília: Brazilian Ministry of Health, Health Surveillance Secretariat, STD, AIDS and Viral Hepatitis Department, März. Google Scholar öffnen DOI: 10.5771/9783845262321
  556. MS (2012), Estratégia para Incentivo da Produção de Fármacos no Brasil, 6º Encontro Nacional de Inovação em Fármacos e Medicamentos, Brasília. Google Scholar öffnen DOI: 10.5771/9783845262321
  557. MS (2013a), Parcerias de Desenvolvimento Produtivo, Coordenação-Geral de Base Química e Biotecnológica Departamento do Complexo Indústrial e Inovação em Saúde, Brasília: Ministerio da Saúde, <http://portal.saude.gov.br/portal/ Google Scholar öffnen DOI: 10.5771/9783845262321
  558. arquivos/pdf/PDP_Plano_de_desenvolvimento.pdf>. Google Scholar öffnen DOI: 10.5771/9783845262321
  559. MS (2013b), Relação Nacional de Medicamentos Essenciais Brasília, 08.08.13, <http://portal.saude.gov.br/portal/arquivos/pdf/rename_anexos_versao_08_08_2013.pdf>. Google Scholar öffnen DOI: 10.5771/9783845262321
  560. MSCI ESG Research (2012), Methodology Report 2012: Stakeholder Review, Haarlem: Access to Medicine Foundation, May 2012, <http://www.accesstomedicine Google Scholar öffnen DOI: 10.5771/9783845262321
  561. index.org/sites/www.accesstomedicineindex.org/files/2012_Methodology_Report_-_Stakeholder_Review_-_May_2012.pdf>. Google Scholar öffnen DOI: 10.5771/9783845262321
  562. MSF (2011), India Rejects Patents for Two Key AIDS Drugs, Geneva, 07.01.11, <http://www.msfaccess.org/about-us/media-room/press-releases/india-re Google Scholar öffnen DOI: 10.5771/9783845262321
  563. jects-patents-two-key-aids-drugs>. Google Scholar öffnen DOI: 10.5771/9783845262321
  564. MST (2013), Science, Technology and Innovation Policy 2013, New Delhi: Government of India: Ministry of Science and Technology. Google Scholar öffnen DOI: 10.5771/9783845262321
  565. Mugabe, John O. (2005), Health Innovation Systems in Developing Countries: Strategies for Building Scientific and Technological Capacities, Background Paper Prepared for the Commission on Intellectual Property, Innovation and Public Health, Geneva: World Health Organization,. Google Scholar öffnen DOI: 10.5771/9783845262321
  566. NACO (2013), Annual Report 2012-13, National AIDS Control Organisation Department of AIDS Control, Government of India, Ministry of Health & Family Welfare, New Delhi. Google Scholar öffnen DOI: 10.5771/9783845262321
  567. Nair, Gopakumar G. (2008a), Impact of TRIPS on Indian Pharmaceutical Industry, Journal of Intellectual Property Rights, 13, 432-441. Google Scholar öffnen DOI: 10.5771/9783845262321
  568. Nair, MD (2008b), Compromizing TRIPS: Brazil's Approach to Tackle the HIV/AIDS Imbroglio, Journal of Intellectual Property Rights, 13, 456-463. Google Scholar öffnen DOI: 10.5771/9783845262321
  569. Nassif, André (2007), National Innovation System and Macroeconomic Policies: Brazil and India in Comparative Perspective, Discussion Papers, No. 184, Geneva: United Nations Conference on Trade and Development. Google Scholar öffnen DOI: 10.5771/9783845262321
  570. Neeraj, Shekhar Sumeet (2011a), Indian Pharmaceuticals Industry: A comprehensive review report, Visakhapatnam, 05. Mai, <http://de.scribd.com/doc/54681742/Best-Pharma-Industry-Report-2011-India>. Google Scholar öffnen DOI: 10.5771/9783845262321
  571. Neeraj, Sumeet Shekhar (2011b), India Pharmaceutical-Industry as an Export Sector, Visakhapatnam, 17. Januar, <http://www.scribd.com/doc/48571412/ Google Scholar öffnen DOI: 10.5771/9783845262321
  572. Indian-Pharmaceutical-Export-Industry>. Google Scholar öffnen DOI: 10.5771/9783845262321
  573. Neeraj, Sumeet Shekhar (2011c), Indian Pharmaceuticals Export Industry: Contemporary scenario, critical analysis & future trends, Visakhapatnam, 05. Oktober, <http://de.scribd.com/doc/68899825/Latest-Best-Rated-Pharma-Industry-Re Google Scholar öffnen DOI: 10.5771/9783845262321
  574. port-India-2011-2012>. Google Scholar öffnen DOI: 10.5771/9783845262321
  575. Nelson, Richard R. (1993), National Innovation Systems: A Comparative Analysis, New York: Oxford University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  576. Nelson, Richard R. & Sidney G. Winter (1982), An Evolutionary Theory of Economic Change, Cambridge: Harvard University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  577. Niosi, Jorge (2002), National systems of innovations are «x-efficient” (and x-effective): Why some are slow learners, Research Policy, 31(2), 291-302. Google Scholar öffnen DOI: 10.5771/9783845262321
  578. Niosi, Jorge (2011), Building innovation systems: an introduction to the special section, Industrial and Corporate Change, 20(6), 1637-1643. Google Scholar öffnen DOI: 10.5771/9783845262321
  579. Niosi, Jorge & Bertrand Bellon (1994), The global interdependence of national innovation systems: Evidence, limits, and implications, Technology in Society, 16(2), 173-197. Google Scholar öffnen DOI: 10.5771/9783845262321
  580. Niosi, Jorge et al. (1993), National Systems of Innovation: In Search of a Workable Concept, Technology in Society, 15(2), 207-227. Google Scholar öffnen DOI: 10.5771/9783845262321
  581. Nohlen, Dieter (2004), Vergleichende Methode, in: Dieter Nohlen & Rainer-Olaf Schultze (Hrsg.), Lexikon der Politikwissenschaft, 2. Auflage, München: Beck. Google Scholar öffnen DOI: 10.5771/9783845262321
  582. Nohlen, Dieter & Rainer-Olaf Schultze (2002), Lexikon der Politikwissenschaft, 2. Auflage, München: Beck Verlag. Google Scholar öffnen DOI: 10.5771/9783845262321
  583. Nortec (oJ), Portfólio Mercado Exportação, <http://www.nortecquimica.com.br/ Google Scholar öffnen DOI: 10.5771/9783845262321
  584. produtos/2/portfolio-mercado-exportacao.html>. Google Scholar öffnen DOI: 10.5771/9783845262321
  585. Nowotny, Helga, Peter Scott & Michael Gibbons (2001), Re-Thinking Science: Knowledge and the Public in an Age of Uncertainty, Cambridge: Polity Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  586. NRDC (2011), Annual Report 2010-11, New Delhi. Google Scholar öffnen DOI: 10.5771/9783845262321
  587. Nugent, Rachel (2008), Chronic Diseases in Developing Countries: Health and Economic Burdens, Annals of the New York Academy of Sciences, 1136, 70-79. Google Scholar öffnen DOI: 10.5771/9783845262321
  588. Nunnenkamp, Peter (1998), Lateinamerika nach der verlorenen Dekade - eine Zwischenbilanz der Reformen, Kieler Diskussionsbeiträge, Kiel: Institut für Weltwirtschaft,. Google Scholar öffnen DOI: 10.5771/9783845262321
  589. NZZ (2013), Patentschutz in Indien: Roche entschärft Politikum, Neue Zürcher Zeitung, 16.08.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  590. Obinger, Herbert (2009), Vergleichende Politikanalyse: Eine Einführung in makro-quantitative und makro-qualitative Methoden, in: Klaus Schubert & Nils C. Bandelow (Hrsg.), Lehrbuch der Politikfeldanalyse 2.0, München: Oldenbourg, 221-244. Google Scholar öffnen DOI: 10.5771/9783845262321
  591. Octaviani, Alessandro (2010), Biotechnology in Brazil: Promoting Open Innovation, in: Lea Shaver (Hrsg.), Access to Knowledge in Brazil: New Research on Intellectual Property, Innovation and Development, London: Bloomsbury Academic, 79-102. Google Scholar öffnen DOI: 10.5771/9783845262321
  592. Oguamanam, Chidi (2004), Localizing Intellectual Property in the Globalization Epoch: The Integration of Indigenous Knowledge, Indiana Journal of Global Legal Studies, 11(2), 135-169. Google Scholar öffnen DOI: 10.5771/9783845262321
  593. Ohly, Christopher (2012), The New India Guidelines On Similar Biologics Regulatory and Market Authorization Requirements, 08.10.12, <http://spicyip.com/docs/ Google Scholar öffnen DOI: 10.5771/9783845262321
  594. The-New-India-Biosimilar-Guidelines-(End-Notes)(Final)-10.08.12.pdf>. Google Scholar öffnen DOI: 10.5771/9783845262321
  595.   Google Scholar öffnen DOI: 10.5771/9783845262321
  596. Oliveira, Maria Auxiliadora et al. (2006 ), Protección de Patentes Farmacéuticas en Brasil: Quien se Beneficia?, in: Jorge A. Bermudez & Maria Auxiliadora Oliveira (Hrsg.), La Propriedad Intelectual En El Contexto Del Acuerdo De La OMC Sobre Los ADPIC: Desafíos Para La Salud Pública, Rio de Janeiro: Centro Colborado de OPS/OMS en Políticas Farmacéuticas, Escuela National de Salud Pública Sergio Arouca, Fundación Oswaldo Cruz, 175-191. Google Scholar öffnen DOI: 10.5771/9783845262321
  597. Orsi, Fabienne et al. (2003), Intellectual Property Rights, Anti-AIDS Policy and Generic Drugs: Lessons from the Brazilian Public Health Program, in: Jean-Paul Moatti et al. (Hrsg.), Economics of AIDS and Access to HIV/AIDS Care in Developing Countries: Issues and Challenges, Paris: ANRS, Collection Sciences Sociales et Sida, 109-135. Google Scholar öffnen DOI: 10.5771/9783845262321
  598. Ortiz, Michael (2013), Varieties of Innovation Systems: The Governance of Knowledge Transfer in Europe, Frankfurt: Campus Verlag. Google Scholar öffnen DOI: 10.5771/9783845262321
  599. OSDDI (2009), "Open Source Drug Discovery": An Open Collaborative Drug Discovery Model for Tuberculosis, Proposal Submitted before 'WHO Expert Working Group on R&D Financing', New Delhi. Google Scholar öffnen DOI: 10.5771/9783845262321
  600. OSEC (2010), Brazil's Pharmaceutical Industry: Opportunities for Swiss Suppliers, Zürich: Business Network Switzerland, 22. März. Google Scholar öffnen DOI: 10.5771/9783845262321
  601. Oyelaran-Oyeyinka, Banji (2005), Systems of Innovation and Underdevelopment: An Institutional Perspective, INTECH Discussion Paper 2005-1, Maastricht: United Nations University, Institute for New Technologies. Google Scholar öffnen DOI: 10.5771/9783845262321
  602. Oyelaran-Oyeyinka, Banji & Gehl Padmashree Sampath (2007), Learning Through Inter-organizational Interactions: Public Research Institutes in the Nigerian (Bio)pharmaceutical System of Innovation, European Journal of Development Research, 19(1), 174-193. Google Scholar öffnen DOI: 10.5771/9783845262321
  603. PAHO & USAID (2008), Health Systems and Services Profile: Brazil, Brasília: Pan American Health Organisation, USAID. Google Scholar öffnen DOI: 10.5771/9783845262321
  604. Paranhos, Julia & Lia Hasenclever (2011), O Relacionamento Entre Empresas Farmacêuticas e as Instituções de Ciência e Tecnologia no Brasil: Contribuições a Partir de Uma Pesquisa de Campo, Artigo em progresso a ser enviado para o XIV Congresso Latino-iberoamericano de Gestión Tecnológica, Lima, 19.-21. Oktober. Google Scholar öffnen DOI: 10.5771/9783845262321
  605. Parker, Rachel (2006), Small Business and Entrepreneurship in the Knowledge Economy: A Comparison of Australia and Sweden, New Political Economy, 11(2), 201-226. Google Scholar öffnen DOI: 10.5771/9783845262321
  606. Parto, Saeed, Tommaso Ciarli & Saurabh Arora (2006), Economic Growth, innovation systems and institutional change, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen DOI: 10.5771/9783845262321
  607. Patel, Parimal & Keith Pavitt (1994), Uneven (and Divergent) Technological Accumulation among Advanced Countries: Evidence and a Framework of Explanation, Industrial and Corporate Change, 3(3), 759-787. Google Scholar öffnen DOI: 10.5771/9783845262321
  608. Pavitt, Keith (1984), Sectoral patterns of technical change: Towards a taxonomy and a theory, Research Policy, 13, 343-373. Google Scholar öffnen DOI: 10.5771/9783845262321
  609. Pedersen, Jorge Dige (2008), Globalization, Development and the State. The Performance of India and Brazil since 1990, Basingstoke: Palgrave Macmillan. Google Scholar öffnen DOI: 10.5771/9783845262321
  610. Pefile, Sibongile (2005), Developing Innovative Capacity in South Africa to Meet Health Needs, in: Ingrid Hering (Hrsg.), Innovation in Developing Countries to Meet Health Needs: Experiences of China, Brazil, South Africa and India, Oxford: The Centre for Management of IP in Health R&D, 7-36. Google Scholar öffnen DOI: 10.5771/9783845262321
  611. Penchansky, Roy & J. William Thomas (1981), The Concept of Access: Definition and Relationship to Consumer Satisfaction, Medical Care, 19(2), 127-140. Google Scholar öffnen DOI: 10.5771/9783845262321
  612. Perez, Carlota (1985), Microelectronics, Long Waves and World Structural Change: New Perspectives for Developing Countries, World Development, 13(3), 441-463. Google Scholar öffnen DOI: 10.5771/9783845262321
  613. Perez, Carlota (2001), Technological Change and Opportunities for Development as a Moving Target, CEPAL Review, 75, 109-130. Google Scholar öffnen DOI: 10.5771/9783845262321
  614. Perez, Carlota & Luc Soete (1988), Catching up in technology: entry barriers and windows of opportunity, in: Giovanni Dosi et al. (Hrsg.), Technical Change and Economic Theory, London: Pinter, 458-479. Google Scholar öffnen DOI: 10.5771/9783845262321
  615. Peterson, M. J. (2010), Case Study: Access to HIV Treatments in Developing Countries - Appendix E: Understanding Drug Patents, in: International Dimensions of Ethics Education in Science and Engineering, Amherst: University of Massachusetts. Google Scholar öffnen DOI: 10.5771/9783845262321
  616. Pharmabiz.com (2012a), India, China most preferred CRAMS destinations, 10.05.12, <http://pharmabiz.com/PrintArticle.aspx?aid=68944&sid=0>. Google Scholar öffnen DOI: 10.5771/9783845262321
  617. Pharmabiz.com (2012b), Indian pharma companies obtains 144 ANDA approvals from US FDA in 2011, 02.01.12, <http://pharmabiz.com/NewsDetails. aspx?aid=66831 Google Scholar öffnen DOI: 10.5771/9783845262321
  618. &sid=2>. Google Scholar öffnen DOI: 10.5771/9783845262321
  619. Pharmalot (2008), Brazil Rejects Gilead Patent On HIV Drug, 09.03.08. Google Scholar öffnen DOI: 10.5771/9783845262321
  620. PharmaTimes (2008), Brazil rejects Gilead patent for HIV/AIDS drug Viread, 04.09.08. Google Scholar öffnen DOI: 10.5771/9783845262321
  621. PharmExec (2013), Drug Patents Under Fire in Brazil, PharmExecBlog, 04.06.13. Google Scholar öffnen DOI: 10.5771/9783845262321
  622. Philip, Kavita (2008), Producing Transnational Knowledge, Neoliberal Identities, and Technoscientific Practice in India, in: Beatriz da Costa & Kavita Philip (Hrsg.), Tactical Biopolitics: Art, Activism, and Technoscience, Cambridge: The MIT Press, 243-267. Google Scholar öffnen DOI: 10.5771/9783845262321
  623. Pietrobelli, Carlo & Roberta Rabellotti (2006), Clusters and Value Chains in Latin America: In Search of an Integrated Approach, in: Carlo Pietrobelli & Roberta Rabellotti (Hrsg.), Upgrading to Compete: Global Value Chains, Clusters, and SMEs in Latin America, Washington, D.C.: Inter-American Development Bank, 1-40. Google Scholar öffnen DOI: 10.5771/9783845262321
  624. Pietrobelli, Carlo & Roberta Rabellotti (2009), The Global Dimension of Innovation Systems: Linking Innovation Systems and Global Value Chains, in: Bengt-Åke Lundvall et al. (Hrsg.), Handbook of Innovation Systems and Developing Countries: Building Domestic Capabilities in a Global Setting, Cheltenham: Edward Elgar, 214-238. Google Scholar öffnen DOI: 10.5771/9783845262321
  625.   Google Scholar öffnen DOI: 10.5771/9783845262321
  626. Pietrobelli, Carlo & Roberta Rabellotti (2011), Global Value Chains Meet Innovation Systems: Are There Learning Opportunities for Developing Countries?, World Development, 39(7), 1261-1269. Google Scholar öffnen DOI: 10.5771/9783845262321
  627. PIJIP (2008), Timeline on Brazil's Cumpulsory Licensing, Program on Information Justice and Intellectual Property, Washington, D.C.: American University Washington College of Law. Google Scholar öffnen DOI: 10.5771/9783845262321
  628. Porter, Michael E. (1990), The Competitive Advantage of Nations, London: Macmillan. Google Scholar öffnen DOI: 10.5771/9783845262321
  629. Poth, Robert (1998), Faire WTO?, April 1998, <http://www.rpoth.at/pastwork/ Google Scholar öffnen DOI: 10.5771/9783845262321
  630. WTODISP1.shtml>. Google Scholar öffnen DOI: 10.5771/9783845262321
  631. Póvoa, Luciano Martins Costa, Roberto Mazzoleni & Thiago Caliari (2011), Innovation in the Brazilian Pharmaceutical Industry post-TRIPS, 9th GLOBELICS International Conference: Creativity, Innovation and Economic Development, Buenos Aires, 15.-17. November. Google Scholar öffnen DOI: 10.5771/9783845262321
  632. Powell, Walter W. (1990), Neither Market Nor Hierarchy: Network Forms of Organization, Research in Organizational Behavior, 12, 295-336. Google Scholar öffnen DOI: 10.5771/9783845262321
  633. Pradhan, Jaya Prakash (2008), Indian Direct Investment in Developing Countries: Emerging Trends and Development Impacts, MPRA Papers, No. 12323, Munich: University Library of Munich. Google Scholar öffnen DOI: 10.5771/9783845262321
  634. Przeworski, Adam & Henry Teune (1970), The Logic of Comparative Social Inquiry, New York: Wiley. Google Scholar öffnen DOI: 10.5771/9783845262321
  635. Public Citizen (2013), The Non-Discriminatory Nature of India’s National Pharmaceutical Pricing Policy: Clarification in Response to the Testimony of Ms. Linda Dempsey, House Energy and Commerce Committee Hearing on India’s Industrial Policy, Washington, D.C.: Public Citizen, <http://www.citizen.org/documents/India Google Scholar öffnen DOI: 10.5771/9783845262321
  636. %20hearing%20rebuttal%20FINAL.pdf>. Google Scholar öffnen DOI: 10.5771/9783845262321
  637. Ragin, Charles C. (1989), The Comparative Method: Moving Beyond Qualitative and Quantitative Strategies, Berkeley: University of California Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  638. Rai, Rajnish Kumar (2009), Effect of the TRIPS-Mandated Intellectual Property Rights on Foreign Direct Investment in Developing Countries: A Case Study of the Indian Pharmaceutical Industry, The Journal of World Intellectual Property, 11(5/6), 404-431. Google Scholar öffnen DOI: 10.5771/9783845262321
  639. Raikes, Philip, Michael Friis Jensen & Stefano Ponte (2000), Global commodity chain analysis and the French filière approach: comparison and critique, Economy and Society, 29(3), 390-417. Google Scholar öffnen DOI: 10.5771/9783845262321
  640. Rajan, Ramkishen S. (2009), Monetary, Investment and Trade Issues in India, New York: Oxford University Press. Google Scholar öffnen DOI: 10.5771/9783845262321
  641. Ramani, Shyama V. (2002), Who is interested in biotech? R&D strategies, knowledge base and market sales of Indian biopharmaceutical firms, Research Policy, 31(3), 381-398. Google Scholar öffnen DOI: 10.5771/9783845262321
  642. Ranbaxy Laboratories Limited (2002), Ranbaxy and Schwarz Pharma Sign a Deal to Develop New Drug to Treat Benign Prostate Hyperplasia, 27.06.02, Google Scholar öffnen DOI: 10.5771/9783845262321
  643. <http://www.ranbaxy.com/ranbaxy-and-schwarz-pharma-sign-a-deal-to-devel Google Scholar öffnen DOI: 10.5771/9783845262321
  644. op-new-drug-to-treat-benign-prostate-hyperplasia/>. Google Scholar öffnen DOI: 10.5771/9783845262321
  645. Ranbaxy Laboratories Limited (2008), Annual Report, Haryana, <http://www.ran baxy.com/wp-content/uploads/2012/ranbaxy_ar2008_3deluxe.pdf>. Google Scholar öffnen DOI: 10.5771/9783845262321
  646. Randeria, Shalini (2007), The State of Globalization: Legal Plurality, Overlapping Sovereignties and Ambiguous Alliances between Civil Society and the Cunning State in India, Theory, Culture & Society, 24(1), 1-33. Google Scholar öffnen DOI: 10.5771/9783845262321
  647. Rao, J. Manohar (2006), Globalization, Technology and Competition: Indian Pharmaceutical Industry in the Context of the WTO, Hyderabad: Media House Publications. Google Scholar öffnen DOI: 10.5771/9783845262321

Ähnliche Veröffentlichungen

aus der Reihe "Vergleichende Analyse politischer Systeme"
Cover des Buchs: Zwischen Heimatschutz und Klimaleugnung
Monographie Kein Zugriff
Marius Fröhle
Zwischen Heimatschutz und Klimaleugnung
Cover des Buchs: Auf dem Weg zum »Präsidialsystem alla Turca?«
Monographie Kein Zugriff
Mahir Tokatlı
Auf dem Weg zum »Präsidialsystem alla Turca?«
Cover des Buchs: Don't Steal My Steel
Monographie Kein Zugriff
Ruth Beckmann
Don't Steal My Steel
Cover des Buchs: Die Vermittlung von Reformen in Zeiten der Krise
Monographie Kein Zugriff
Pascal König
Die Vermittlung von Reformen in Zeiten der Krise
Cover des Buchs: Wohlfahrtsstaatliche Strukturen und Parteieneffekte
Monographie Kein Zugriff
Frank Bandau
Wohlfahrtsstaatliche Strukturen und Parteieneffekte

Hinweis

Dieses Werk ist urheberrechtlich geschützt und darf nur nach den Vorgaben der Nutzungs- und Lizenzvereinbarung genutzt werden. Jede darüber hinaus gehende Nutzung des Werkes ist ausdrücklich untersagt und wird verfolgt.

Feedback geben

Wir freuen uns über Ihr Feedback zu Inhalten und Funktionen. Ihre Nachricht hilft uns, unseren Service stetig zu verbessern.

Bewertung
Bild anhängen
oder hier ablegen
PNG oder JPG (max. 3 MB)

Anmelden

Passwort vergessen?
Login über Ihre Institution (SSO, Shibboleth, OpenAthens)
Noch kein Benutzerkonto?
Jetzt registrieren

Publikation zitieren

Download: RIS BibTex